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Abstract 
 
Context:  Canadian best practice recommendations for identification and treatment of post-
stroke depression (PSD) have been established, but whether they have been adopted is not 
known.   
Objectives:  To compare current with recommended best practice.  
 
Methods: A retrospective chart review from 5 inpatient rehabilitation programs in Southwestern 
Ontario was completed and a short online survey addressing current practices, opinions and 
attitudes regarding PSD conducted.   
Results:  Screening for PSD was documented in 41 of 294 patient records. Of the 41 patients 
screened, 16 were referred for assessment and 6 diagnosed with PSD. However, 113 patients 
(38.9%) received pharmacotherapy.  Most staff members reported having access to the 
recommendations (75%) and were somewhat aware of recommendations for PSD (70%).    
Conclusion: A substantial gap exists between current practice and best practice for the 
identification and treatment of PSD.  Respondents expressed positive attitudes toward best 
practice and identified few barriers suggesting clinicians may be willing to implement the 
recommendations.   
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Chapter 1 
1. Introduction  
Cerebrovascular disease, in general, and stroke, in particular, is a major health concern 
worldwide.  According to the Global Burden of Disease Study, stroke is the second most 
common cause of death.1  Although stroke is perceived primarily as a disease of the elderly, it is 
reported to be a significant cause of death even among people aged 15 to 44 years of age.1  It is 
estimated that for every 5 individuals who experience stroke, one is under the age of 65 years 
and approximately 5 to 8% of all persons with stroke are under the age of 45 years.2-4 The 
average age of individuals who experience a stroke is 70 years in men and 75 in women, and in 
excess of one-half of all strokes occur in adults over the age of 75.5  Based on a 51-year follow-
up of persons enrolled in the Framingham Study, lifetime risk for stroke in individuals aged 55 to 
75 was estimated to be approximately 1 in 6 overall and 1 in 5 for women, based on a longer 
female life expectancy.6 
While stroke has a substantial impact on worldwide mortality, the majority of stroke events 
are not fatal.  In a review of population-based epidemiological studies that included more than 
3.2 million participants in 13 countries, Feigin et al5 reported an estimated case-fatality of 22.9% 
within 1 month of stroke onset based on data provided in 13 of 15 identified studies.  Although 
Feigin and associates reported little geographical variation in reported case-fatality rates,5 North 
American-based estimates of stroke-related fatality are lower.  In a study of 11 Canadian stroke 
centres in which 3,756 individuals with stroke were enrolled over a 2-year period (2003 to 2005), 
overall case fatality was estimated to be 6.9%, 12.6% and 23.6% at 7 days, 30 days and 1 year, 
respectively.7  Similarly, authors of the North Manhattan Stroke Study reported one-month case-
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fatality rates of 16% in participants aged 45 or older and 17% in those under the age of 45 years.3   
In addition, rates of both death and hospital admission attributable to stroke are declining over 
time, particularly in the Americas, Western Europe and parts of Oceania.5, 8, 9  Based on data 
from the Canadian Mortality Database and information from the Canadian Institute for Health 
Information’s Hospital Morbidity Database for the period of 1994 to 2004, the Canadian 
Cardiovascular Outcomes Research Team reported a decline in the age and sex-standardised 
stroke mortality rate of 28.2% (per 100,000 population over the age of 20 years) and in post-
stroke hospital admission rates of 27.6%.9   It is worth noting that, although the overall rates of 
hospital admission declined, the proportion of elderly patients admitted to hospital following 
stroke increased.  As stroke incidence rates increase substantially for both men and women with 
each additional decade of age,5 and mortality rates from stroke continue to decrease, the make-up 
of the hospitalised population, in both acute and sub-acute care settings also shifts to include a 
greater proportion of elderly individuals who have experienced stroke and who may require 
additional care once they are discharged from hospital.  Of those individuals who survive a 
stroke, only 65% may be functionally independent 1 year following the stroke event.10  In 
Canada, it has been estimated that 4.1% of all individuals over the age of 65 are living with the 
consequences of stroke.11  
It is clear that focusing on mortality alone does not provide an accurate representation of 
the burden of disease associated with stroke.  In the Global Burden of Disease Study, stroke was 
identified as the sixth leading cause of burden assessed in terms of disability or DALYs, defined 
as total life years lost due to premature mortality and years lived with disability adjusted for 
severity.12   The fourth leading cause of disease burden is depression, which also is a common 
consequence of stroke.12-14   In low- to middle-income countries, both stroke and depression are 
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significant contributors to disability for elderly individuals.15  The proportion of severe disability 
that could be avoided if exposure to these conditions were removed is estimated to be 11.4% for 
stroke and 8.3% for depression.15   
1.1 What is Post-Stroke Depression?  
In the Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision 
(DSM-IV-TR) depression is defined as a persistent and prominent mood disturbance 
characterised by depressed mood or a significantly reduced interest or pleasure in all or almost 
all activities.16  When a mood disturbance is attributed directly to a specific medical condition, it 
is categorised as a “Mood Disorder due to a General Medical Condition” (see Table 1).  Authors 
of the DSM-IV-TR recommend that both major and minor depression be distinguished further 
from a “Mood Disorder due to a General Medical Condition” when the identified mood 
disturbance is considered to be a direct consequence of a specific medical condition such as 
stroke.  Post-stroke depression (PSD), is classified as a Mood Disorder due to Stroke with either 
major-depressive-like episodes (major depression) or depressive features (minor depression).  At 
present, the criteria provided by the DSM-IV-TR are the gold standard against which a diagnosis 
of PSD is made. 
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Table 1. DSM-IV-TR Diagnostic criteria for Mood Disorder due to a General 
Medical Conditiona  
 
Mood disorder due to a General Medical Condition (stroke)  
A.  Persistent and prominent disturbance in mood characterized by “depressed mood or markedly 
diminished interest or pleasure in all, or almost all, activities” and/or “elevated, expansive, or 
irritated mood”. 
B.  Evidence (patient history, physical examination or laboratory findings) that the disturbance is a 
direct physiological consequence of the medical condition  
C.  Disturbance is not better explained by another mental disorder.  
D.  Disturbance does not occur during the course of delirium.   
E.  Symptoms of the disturbance result in significant distress or impairment in social, occupational 
or other important areas of function.   
Type   
1) With depressive features – depression is dominant, but criteria for major depression is not 
fulfilled 
2) With major-depressive-like episode – criteria for major depression is met (excl. D – see below) 
3) With manic features – dominant mood is elevated, euphoric or irritable 
4) With mixed features – both depression and elevation are present, but neither dominates 
Criteria for Major Depression  
A.  ≥5 symptoms present during same 2 week period and represent a change in function; one 
symptom must be either depressed mood or loss of interest  
1. depressed mood most of the day, for most days  
2. marked reduction in interest or pleasure in most activities 
3. significant weight loss or gain; significant increase or decrease in appetite  
4. insomnia or hypersomnia 
5. psychomotor agitation or retardation  
6. fatigue or loss of energy  
7. feelings of worthlessness; inappropriate guilt  
8. reduced ability to think or concentrate; indecisiveness  
9. recurrent thoughts of death; suicidal ideation 
B. Symptoms do not meet criteria for mixed episode  
C. Symptoms cause significant distress or impairment in important areas of function  
D. Symptoms are not due to the direct, physiological effects of a substance or general medical 
condition.   
E. Symptoms are not better accounted for by bereavement.   
 aDSM-IV-TR, American Psychiatric Association16. 
Concerns have been raised regarding the use of the criteria provided in the Diagnostic and 
Statistical Manual for the assessment and diagnosis of post-stroke depression (PSD).  As written, 
the diagnostic criteria include vegetative symptoms such as psychomotor retardation, fatigue, 
sleep and appetite disturbances which could be a consequence of the stroke.  The possible 
overlap between depressive symptomatology and stroke sequelae could make interpretation of 
the possible cause of these symptoms more difficult.  Morris et al17 suggested that the somatic 
features of depression, such as slowness or lethargy and behavioural disturbances, might be more 
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prominent in depression associated with physical illness while other symptoms, such as feelings 
of low self-esteem, guilt and self-recrimination, occur less frequently.  Gainotti et al18 
demonstrated that the motivated or reactive aspects of depression may be more prevalent in 
individuals who experience depression following stroke, suggesting that PSD may be, at least in 
part, a negative mood reaction to the physical consequences of stroke and the associated losses to 
the individual.     
Alternatively, it has been suggested that the DSM criteria for depression are as valid for 
individuals who have experienced stroke as they are for general psychiatric evaluations.  For 
example, Spalletta et al19 reported that vegetative symptoms appearing in the DSM-IV were as 
discriminative of the presence of major and minor depression in a group of stroke patients as 
were the psychological and cognitive criteria.  More recently, Cumming et al20 demonstrated that 
the experience of depression in individuals with stroke is similar, though perhaps not identical, to 
age and sex-matched controls without stroke.  Individuals with depression in the non-stroke 
control group were significantly more likely than individuals with PSD to report symptoms of 
anhedonia (p=0.002) and disturbed sleep (p=0.008).  There were, however, no differences in 
scores on either the somatic or psychological factors of depression between the depressed 
controls vs. those in the PSD group.20 
1.2 Prevalence and Natural History of Post-Stroke Depression  
Depression is a well-documented sequela of stroke. Based on pooled data from published 
prevalence studies, Robinson21 reported a mean prevalence of depression among inpatients in 
acute or rehabilitation hospital settings of 19.3% and 18.5% for major and minor depression, 
respectively.  Among participants in outpatient studies, mean reported prevalence was 23.3% for 
major depression and 15% for minor depression.  Overall, mean prevalence was 35.5% in acute 
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care or rehabilitation hospital settings and 31.8% in community-based studies.21  Similarly, in a 
systematic review of  51 prospective, observational studies of post-stroke depression conducted 
in  hospital-,  rehabilitation-, and population-based settings, Hackett et al14 estimated that 33% of 
individuals who experience stroke exhibit depressive symptoms at some time following the event 
(i.e., at acute, sub-acute or long-term follow-up).  The authors stated that this is likely to be an 
underestimation of the frequency with which post-stroke depression (PSD) occurs given possible 
under-reporting of unusual mood, difficulties in the assessment of depression in neurologically-
impaired individuals, and variability in the methods used to assess and define cases of depression 
within the literature.14   
Of course, the time from stroke onset to assessment of depression may also have an effect 
on estimates of prevalence.  Individuals assessed during the sub-acute phase post stroke may be 
experiencing a period of transition during which they are attempting to adjust to the 
consequences associated with a traumatic event.22  At this point, symptoms of depression may 
simply be a reflection of the difficulties associated with this transition and, in fact, the highest 
rates of incident depression have been reported within the first month of the stroke event.23-28   
Paolucci et al29 reported that, of 1064 patients included in the Italian DESTRO study, 36% 
developed depression.  Eighty percent of these became depressed within the first 3 months of the 
stroke event.  In that study, minor depression was the most common form of depression 
documented, occurring in 80.7% of cases, whereas major depression was diagnosed in only 
2.9%. 
Incident rates of post-stroke depression do not remain stable over time.  In a recent study of 
190 individuals with first-ever stroke, Bour et al28 reported a decrease in incident cases of 
depression over the course of the first year following the stroke event.  Cumulative incidence of 
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PSD was 18.8% at 1month and 23.1%, 26.7%, 31%, and 36.2% at 3, 6, 9 and 12 months, 
respectively.  Although incident rates decline over time and a general trend toward improvement 
in depressive symptomatology is evident in the first year post stroke,30 PSD may prove to be 
persistent for a significant proportion of individuals identified as depressed.30-33 Ostir et al30 
examined patterns of change in depressive symptomatology over the course of the first year 
following first-ever stroke in 544 individuals.  At the time of discharge from inpatient 
rehabilitation, 27.6% of patients were identified as depressed.  Over the following 12 months, the 
authors identified a general trend toward recovery in terms of depressive symptomatology.  
However, approximately one-fifth of individuals identified as depressed at baseline remained 
depressed at 1 year; for approximately one-third of this group, depression remained largely 
unresolved and they continued to experience episodes of depression during the follow-up 
period.30   
Ayerbe et al31followed individuals (n=3689) for 5 years as part of a population-based study 
(South London Stroke Register).  Over this period, the prevalence of PSD was reported to be 
33%, 28%, 32% and 31% at 3 months, 1 year, 3 years and 5 years, respectively.  While some 
identified cases of depression appeared to resolve over time, 15 to 20% of individuals identified 
as depressed at each follow-up were new cases.  In addition, more than one-half of individuals 
identified as depressed at any one assessment point remained depressed on subsequent follow-up 
(Ayerbe et al. 2011).31   Similarly, Farner et al32 reported persistent depression in 55% of 
individual study participants identified as depressed during inpatient rehabilitation post stroke.  
Significant predictors of persistent depression included lower levels of pre-stroke social activity, 
greater severity of stroke and lower levels of function at baseline.     
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1.3 Consequences Associated with Post-Stroke Depression 
Depression in individuals with stroke is associated with enormous personal, social and 
financial costs that include poorer functional recovery and increased risk for dependence, poorer 
cognitive function, including impaired executive function, and reductions in social participation.  
Within each area (i.e., physical function, cognition and social participation), reciprocal 
relationships have been identified; poorer function, poorer cognition and greater social isolation 
also are significant risk factors for depression creating the potential, particularly in untreated 
cases of depression, for a downward spiral in outcomes.   The presence of PSD also is associated 
with increased risk for mortality.     
1.3.1 Functional Impairment and PSD 
Research has demonstrated a significant association between dependence in function and 
the presence of depression during the acute, sub-acute and longer-term or chronic periods 
following stroke.34-41  As part of the United Kingdom (UK) Stroke Outcomes Study, physical 
function and psychological symptoms were assessed at baseline (2 to 6 weeks post stroke) and 
again at 9, 13, 26 and 52 weeks.  Participants identified as being at risk for poor physical 
outcome at 1 year post stroke included those who were older, had more severe disability soon 
after the stroke event, and experienced persistent symptoms of depression over the first six 
months of follow-up.40  Similarly, Willey et al41 demonstrated a significant association between 
depressed mood and functional ability such that the presence of depression within the first 2 
weeks of stroke was associated with significantly greater odds for severe disability at both 1 and 
2 years post stroke (OR= 2.91, 95% CI 1.07-7.91 and OR=3.72, 95% CI 1.29-10.71).  In 
addition, time does not appear to reduce the association between depressive symptomatology and 
the risk for poor functional outcome. Feigin et al39 reported results of a 5-year follow-up of 
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participants enrolled in the Auckland Stroke Outcomes Study.  At 5 years, approximately 30% of 
participants reported experiencing symptomatology suggestive of the presence of depression.  
Individuals experiencing depressive symptomatology were more likely to experience dependence 
(OR = 4.58, 95% CI 2.48, 8.46), reduced Instrumental Activities of Daily Living (IADL) activity 
(OR = -4.55, 95% CI -6.29 to -2.81) and lower levels of social participation (OR = -7.48, 95%  
CI -11.06 to -3.9) than individuals with no depression.39   
While individuals who experience depression following stroke do have an increased risk 
for poorer functional outcome, they also experience significant recovery over time.  However, 
over the course of recovery, functional ability may begin and end at a lower level than those 
without depression, despite rehabilitation interventions.42-45  In a group of patients with stroke 
admitted to hospital for inpatient rehabilitation, Nannetti and colleagues44 found that both 
patients with and without PSD made significant motor and functional recovery over the course of 
the rehabilitation admission. However, motor recovery was significantly greater for non-
depressed individuals at discharge and at 3 months.  Functional recovery was also significantly 
greater for patients without depression at 3-month follow-up.   
Experienced concurrently, stroke and depression may be associated with greater physical 
limitations than either condition individually.46  Physical impairment and post-stroke depression 
appear to act upon each other, and each influences the recovery of the other. In a prospective 
cohort study (n=205), Van de Port et al47 demonstrated that mobility decline was experienced by 
21% of participants between 1 and 3 years post stroke.  Significant predictors of this decline in 
mobility status were level of activity, cognitive problems, fatigue and depression.  Given that the 
relationship between depression and physical impairment might be reciprocal, depression can 
contribute to a progressive deterioration in mobility which can, in turn, contribute to increased 
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feelings of depression.  As noted by Chodosh et al48, depression, chronic disease, and physical 
function probably have multidirectional relationships that confound attempts to understand 
causation.  
1.3.2  Social Activities and PSD  
Despite the importance of supportive relationships for social integration post stroke, many 
individuals can experience feelings of isolation and separation from both family members and 
friends as relationships are altered, in part, by changes in the way in which individuals perceive 
themselves and their abilities.22, 49, 50  In addition, the experience of depressive symptomatology 
can result in reduced social activity, contact and integration.23, 51-53  A significant inverse 
relationship has been identified between PSD and social integration such that increased 
depressive symptomatology is associated with poorer social integration 6 months following 
stroke.51  Over the first year following stroke, the presence of depressive symptoms can 
significantly increase the odds for social isolation (OR=1.11, 95% CI 1.04, 1.20).53  Sienkiewicz-
Jarosz et al52 reported that 66.2% of individuals with stroke who experienced symptoms of 
depression reported reductions in social contact with both friends and family in terms of both 
frequency and satisfaction.     
As for functional impairment, reductions in social interactions, contacts and relationships 
can be both a risk factor for and a consequence of PSD.  Andersen et al23 reported a significant 
relationship between social distress prior to the stroke event and PSD, suggesting that individuals 
who were isolated socially prior to the stroke event were more likely to become depressed post-
stroke.  Further, individuals with pre-stroke isolation tend to remain isolated,53 which can 
increase risk for depression which, in turn, may lead to greater social isolation.51     
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1.3.3. Cognitive Impairment and PSD 
Observational studies have shown that depression can contribute to cognitive impairment.  
In a prospective, longitudinal study of 2220 community-dwelling individuals aged 65 or older 
and who did not exhibit cognitive impairment at study entry (based on test scores from either the 
Modified Mini Mental State Examination (3MS) or a review of available data that could include 
the 3MS, the Digit Symbol Test, the Benton Visual Retention Test, the Telephone Interview for 
Cognitive Status or Dementia Questionnaire), Barnes et al54 determined that the presence of 
depressive symptomatology at baseline was associated with greater odds for developing mild 
cognitive impairment (OR=1.38 for mild symptoms of depression and 2.20 for moderate to 
severe symptoms).  In studies of depression and cognition following stroke, authors have noted 
that the presence of depression is associated with higher levels of cognitive impairment,23, 28, 55, 56 
and with slower rates of cognitive recovery.57  However, as is the case for many of the identified 
potential consequences of PSD, it is difficult to determine whether cognitive impairment results 
from depression, is a risk factor for depression or both.28, 58, 59  Saxena et al59 reported that the 
odds of experiencing cognitive impairment at 6 months post stroke were significantly associated 
with the presence of depression at the time of discharge from inpatient rehabilitation.  
Conversely, the odds for experiencing depression at 6 months post stroke were associated with 
the presence of cognitive impairment at discharge.59   
1.3.4 Mortality and PSD 
Individuals with depression can experience not only a greater risk for stroke than those 
without depression,60 but also can exhibit a greater risk for stroke-related mortality.61, 62  Based 
on observations from a 29-year follow-up of a large sample of community-dwelling adults, 
Everson and colleagues61 reported that the presence of 5 or more depressive symptoms was 
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associated with a significant increase in risk for mortality from stroke in individuals who were 
healthy and stroke free at the beginning of the surveillance period (HR = 1.66, p<0.006).  This 
association maintained significance after adjustment for education, alcohol consumption, 
smoking, body mass index, hypertension, and diabetes (HR=1.54; p<0.02).   Every single-point 
increase in depressive symptomatology was associated with an 8% increase in risk for stroke 
mortality (p<0.003) (Everson et al. 1998).61  In a 10-year study of older individuals, Kamphuis et 
al62 reported a similar, dose-dependent effect.  Each 5-point increase on the Zung Self-Rating 
Depression Scale was associated with a 35% increase in the risk for death from stroke (HR = 
1.35, 95% CI 1.19 – 1.53 adjusted for country of origin, education, body mass index, smoking, 
alcohol intake, cholesterol levels and level of physical activity).  When compared to those who 
reported little depressive symptomatology at study entry, individuals experiencing high levels of 
symptoms were more than 3 times as likely to die from stroke (HR = 3.41 95% CI 1.69 – 6.90).   
An analysis of data collected from over 10,000 participants in the National Health and 
Nutrition Examination Survey I Epidemiologic Follow-up Study was reported recently.63  Study 
participants were grouped according to the presence of stroke and depression as follows: i) no 
stroke, no depression (reference category), ii) no stroke, depression, iii) stroke, no depression and 
iv) stroke and depression.  Using a multivariate model that accounted for variables considered 
most likely to mediate associations between stroke, depression and mortality, the authors 
demonstrated a significant increase in risk for the primary study outcome of all-cause mortality 
for each category when compared to individuals with neither stroke nor depression.  The 
presence of both stroke and depression resulted in the greatest risk for mortality (HR=1.88, 95% 
CI 1.27, 2.79), though the impact of these factors was not additive.     
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1.3.5 Resource Utilization and PSD 
The presence of depression in the general population has been associated with increased 
healthcare utilization and expenditures in both inpatient and outpatient settings.64-68  This 
includes inpatient admissions, outpatient visits (for primary care physicians, social workers, 
physiotherapists, home care nursing, consulting specialists), laboratory and radiologic tests, ER 
visits, and transportation services.  It has been demonstrated that depression is a significant 
independent predictor of healthcare costs66, 68 such that the presence of each additional symptom 
(as assessed on the Centre for Epidemiological Studies Depression scale) is associated with a 
1.9% increase in associated costs.66  Among older individuals, healthcare use and associated 
costs may be as much as 50% greater for those individuals who experience depression than for 
those who do not.65, 66   
Not surprisingly, given the impact of depression on healthcare resource use in older 
individuals, those who survive stroke and experience PSD may use significantly more healthcare 
resources than non-depressed stroke survivors.  Jia et al69 reported that, within the first 12 
months following stroke, patients with PSD had 1.2 times more inpatient stays, 1.3 times more 
outpatient visits and 1.4 times longer lengths of stay when compared to stroke patients without 
PSD.  In addition, post-stroke depression is associated with reduced functional ability. Level of 
functional ability post stroke is a key predictor of healthcare use and expenditure in the months 
following the stroke event.70-72  Early detection and successful treatment of post-stroke 
depression could reduce total healthcare use and overall costs of care, in part, by limiting the 
impact of depression on functional ability.   
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1.4 Treatment of PSD  
Treatment of post-stroke depression may involve the use of medications, psychosocial or 
behavioral therapies, light therapy or even electro-convulsive treatments.  By far the most 
common approach to treatment of depression following stroke is pharmacotherapy.  In a meta-
analysis of 16 studies examining the use of antidepressants in individuals with PSD, Chen et al73 
reported a significant treatment response (e.g., reduction in depressive symptomatology) 
regardless of the specific definition of response or assessment scale used by individual study 
authors.  The authors also identified a relationship between duration and benefit of treatment.  
Pooled analysis of studies with treatment durations of 1 and 2 weeks revealed no significant 
treatment effects.  However, from 3 weeks onward, effects were of increasing statistical 
significance.  In an updated Cochrane review, Hackett et al.74 included 12 studies examining the 
use of pharmacological interventions for the treatment of PSD.  As in the Chen et al73 review, 
Hackett and colleagues74 included trials examining a variety of agents initiated at a variety of 
times post stroke and for varying intervals.  Using pooled analysis where possible, the authors 
concluded that use of pharmacotherapy was associated with a small, but significant, positive 
treatment effect.   
Unfortunately, there are relatively fewer studies available on the impact of talk-based or 
other non-pharmaceutical therapies in the treatment of post-stroke depression.  As part of their 
review, Hackett et al74 identified and included four trials on the use of psychotherapy, but 
concluded that there was no evidence of benefit associated with its use.  However, use of non-
pharmacologic therapies (e.g., light therapy or psychotherapeutic techniques such as cognitive 
behavioural therapy) can be effective and low-risk adjuvants to antidepressant therapy.75   
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1.4.1 Impact of Pharmacologic Treatment on Rehabilitation Outcomes  
Treatment and subsequent remission of PSD have been associated with both improved 
physical function and cognitive recovery.   In an observational study, Gainotti and colleagues76 
demonstrated that treatment of individuals with PSD with the antidepressant fluoxetine was 
associated with improved functional recovery in addition to remission of symptoms of 
depression.  These observations are well supported by a number of clinical trials examining the 
effectiveness of various antidepressant agents used to treat PSD.77-82  Further, individuals with 
PSD who experience reductions in symptoms may be more likely to achieve functional 
independence by three months post stroke than individuals for whom depression is persistent.83     
The positive influences of treatment with antidepressants for individuals who experience 
PSD may extend well beyond termination of treatment.  In a follow-up study to a randomised 
controlled trial of pharmacological treatment for PSD, Mikami et al82 examined the course of 
functional recovery over a 12-month period. In the original study, antidepressant treatment with 
either nortriptyline or fluoxetine (treatment group) or a matching placebo (control group) was 
administered to participants over a period of 3 months.  At the end of the intervention, 
individuals assigned to receive treatment demonstrated greater recovery in function assessed on 
the modified Rankin Scale when compared to those who were assigned to the placebo condition.  
Follow-up at 6, 9, and 12 months showed that individuals who received antidepressant therapy 
continued to demonstrate significantly better recovery over time despite cessation of treatment at 
3 to 6 months post stroke.  It should be noted that not all participants presented with identifiable 
depression at baseline and that improvements in recovery associated with treatment were not 
dependent on the presence of depression.  Antidepressant therapy was associated with improved 
recovery over a 1-year period in both individuals with and without identifiable depression at 
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baseline.  Although some have suggested that remission of depression may influence the rate of 
recovery,59  the properties of the antidepressant used may have a variety of effects on neural 
mechanisms that could promote recovery independent of reducing depressive symptomatology.82   
Regardless of the mechanisms by which treatment can facilitate recovery, the timing for 
initiation of pharmacotherapy also may be important.  While most clinical trials that examined 
the effectiveness of therapy were initiated more than 1 month after a stroke event, Narushima et 
al81 and Gonzalez-Torrecillas et al77 both focused on treatment beginning within the first month. 
In an open-label study, Gonzalez-Torrecillas and colleagues demonstrated that early treatment 
was associated with significant improvements in physical, cognitive and neurological function by 
the end of the 6-week treatment period77.  Similarly, over a 12-week treatment period, 
Narushima et al81 reported a significantly greater improvement in physical function for 
participants assigned to receive early treatment than for those whose treatment started later.  In 
addition, during an extended period of observation, participants with late onset of treatment 
experienced gradual deterioration in function between 12 and 24 months post stroke, while 
individuals assigned to the early treatment group continued to improve slowly over the same 
period of time.  Logistic regression controlling for treatment type, initial diagnosis, 
presence/absence of motor impairment, past psychiatric history and continued use of medication 
past the end of the treatment phase demonstrated a significant effect of early versus late 
treatment on FIM scores at 12 to 24 months.81   
1.4.2 Impact of Pharmacologic Treatment on Risk for Mortality 
Early treatment with antidepressants, even for a relatively short period, can have a 
prolonged, protective effect on mortality rates following stroke.  As part of a randomized 
controlled trial examining the effectiveness of a 12-week course of antidepressant 
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pharmacotherapy with fluoxetine or nortriptyline (vs. placebo), mortality data were gathered for 
all patients up to 9 years following study entry.84  At 9 years, almost one-half of the original 
study participants had died.  Not surprisingly, surviving participants were significantly younger 
(p=0.0005).  There was no association between the presence of depression at baseline and long-
term outcome. However, probability for survival was significantly greater in those individuals 
who had been assigned to receive pharmacotherapy and in those who had completed the 
prescribed treatment. The authors speculated that the use of antidepressant medications following 
stroke may alter pathophysiological mechanisms associated with mortality or with the 
development of later depression. 
1.5 Evidence-Based Practice and PSD 
In 2003, the Canadian Stroke Network convened an interdisciplinary consensus panel to 
examine and evaluate existing research in the area of stroke rehabilitation in order to identify 
stroke-related problems that were prevalent and whose presence could be significantly 
detrimental to the health-related quality of life of individuals with stroke.  In areas with only 
weak evidence to support associated interventions, the group identified an evidence gap and 
assigned priorities for further research efforts.  In areas considered to have strong evidence for 
effective treatments, the panel assigned priorities for guideline development and knowledge 
translation. Using a modified Delphi approach to reach consensus, three priority areas for 
guideline development and knowledge translation were identified: 1) lower extremity 
interventions, 2) upper extremity interventions and 3) detection of individuals at risk for the 
specific post-stroke complications of depression, dysphagia, cognitive impairment, falls and 
pressure ulcers.85  
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Since that time, evidence-based recommendations for best practice in stroke care have been 
created and updated.86, 87  In keeping with the prioritization of the identification of depression as 
an area for guideline development, the recommendations contained clear statements intended to 
guide standardised screening and diagnostic assessment, as well as treatment for post-stroke 
depression (see Table 2).  Like other, previously-available international guidelines,88 the 
Canadian recommendations acknowledged the importance of a two-step process of identification 
of depression that includes screening with a validated tool and diagnostic evaluation based on a 
clinical interview conducted by an appropriately-trained mental health professional.  Treatment 
recommendations included prescription of an antidepressant medication.   
 
Table 2.  Canadian Best Practice Recommendations for Stroke Care – Post-Stroke 
Depressiona 
 
Screening (identification)  
i All patients with stroke should be screened for depression using a validated tool.  Screening should 
take place at all transition points and whenever clinical presentation indicates.  Transition points may 
include: a) admission to acute care, particularly if any evidence of depression or mood change is 
noted b) before discharge to the community from acute care or during early rehabilitation if 
transferred to an inpatient rehabilitation setting c) periodically during inpatient rehabilitation and d) 
periodically following discharge to the community.   
Diagnosis  
ii Patients identified as being at risk for depression during screening should be referred to a healthcare 
professional with expertise in diagnosis and management of depression in stroke patients.  These 
patients should be referred to a psychiatrist or psychologist where available.   
Treatment 
iii Patients with mild depressive symptoms should be managed by “watchful waiting” with treatment 
being started only if the depression is persistent.   
iv Patients diagnosed with a depressive disorder should be given a trial of antidepressant medication, if 
no contraindication exists. No recommendation is made for the use of one class of antidepressants 
over another; however, side effect profiles suggest that selective serotonin reuptake inhibitors may 
be favoured in this patient population 
v In adult patients with severe, persistent or troublesome tearfulness, selective serotonin reuptake 
inhibitors are recommended 
vi Treatment should be monitored and should continue for a minimum of six months if a good response 
is achieved 
vii Routine use of prophylactic antidepressants is not recommended in post-stroke patients 
aLindsay et al.86, 87  
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Implementation of best practice for the identification and treatment of PSD is necessary to 
maximize each individual’s potential for physical, cognitive and social recovery.  While the use 
of formal screening tools has been associated with improved detection and treatment of 
depression following stroke,89, 90 previous studies in both the UK and USA suggest that rates of 
systematic screening are low.91-93  A recently-published study based on data from the registry of 
the Canadian Stroke Network reported very low prevalence and treatment rates for PSD in acute 
care settings where PSD was considered present given documentation of depression, treatment 
with an antidepressant and a psychiatric consultation or receipt of a new prescription for an 
antidepressant medication post-admission.94  Although, the authors did not attempt to record 
results of formal screening or to evaluate the frequency with which it was performed, they did 
note that the rates of recorded depression were substantially lower than in studies which used 
active screening as their means of identifying the presence of depression.  These findings 
reinforce the need for an effective process of screening and diagnosis for PSD.   
At the present time we do not know the extent to which the Canadian Best Practice 
Recommendations for post-stroke depression have been adopted for use in clinical practice. 
Despite the demonstrated benefits associated with the identification and treatment of PSD and 
the availability of evidence-based practice guidelines such as our own Canadian Best Practice 
Recommendations for Stroke Care, PSD may remain unrecognized and under-treated.  As a first 
step in the ongoing process of knowledge translation and implementation, it is important that 
researchers determine whether current evidence-based recommendations are being followed.95   
 1.6 Study Objectives/Hypotheses 
Primary Objective. The current study sought to examine adherence to the Canadian Best 
Practice Recommendations for post-stroke depression by estimating what proportion of patients 
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admitted for inpatient stroke rehabilitation care in Southwestern Ontario are i) being screened for 
depression using a validated screening tool, ii) receive additional detailed assessment, for the 
purposes of diagnosis, by an appropriately-trained mental health professional and iii) are treated 
for post-stroke depression.  Based on existing literature, it was hypothesized that fewer than 50% 
of patients admitted to inpatient rehabilitation care in Southwestern Ontario following a stroke 
event are screened for depression and that few of those individuals identified with “possible 
depression” are referred for further assessment.  Furthermore, it was hypothesized that a 
substantial proportion of patients receive treatment for depression (i.e., pharmacotherapy) 
without documented screening and formal diagnosis.   
Secondary Objectives:  
1) Since it was hypothesized that treatment rates will exceed that which one might expect 
based on reported assessment and diagnosis, the current study sought to identify factors, 
including patient-level variables such as established risk factors for PSD that, in current 
practice, might influence the decision to initiate treatment in the absence of formal 
screening and assessment.  
2) Given that the results of a practice audit may be used to inform an ongoing process of 
knowledge translation, identification of gaps in care should be supplemented with 
information intended to help us to understand why such gaps in care exist.95  Therefore, 
knowledge and attitudes about PSD and the existing best practice recommendations as well 
as perceived facilitators and barriers to best practice within identified inpatient 
rehabilitations settings were examined.  It was hypothesized that, at the level of the 
healthcare professional, poor adherence to best practice recommendations for post-stroke 
depression might be explained, in part, by provider knowledge/education, skill and 
Best Practices for Post Stroke Depression       21 
 
 
 
attitudes about depression including lack of recognition of the importance of PSD, 
inadequate education and training with regard to recommended best practice, social stigma 
regarding mental illness, and anticipated difficulties around discussing the diagnosis and 
treatment of depression. Additionally, at the organisational level, poor adherence can be 
associated with factors such as poor access to current guidelines, low levels of resources 
designated for mental health post stroke, and having no existing practice policy with regard 
to detection, diagnosis and treatment.   
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Chapter 2 
2.  Method 
2.1 Recruitment of Participant Rehabilitation Programs.   
All facilities (n=7) providing inpatient stroke rehabilitation services in the Southwestern 
region of the Province of Ontario were identified for potential inclusion in the study.   Inpatient 
rehabilitation coordinators, managers and district stroke coordinators associated with the 
rehabilitation programs were identified.  A brief description of the background, purpose and 
method associated with involvement were sent by email to the aforementioned representatives of 
each rehabilitation program along with an invitation to participate in the study.  Each facility 
representative also was contacted by telephone by the investigator (K.L.S.) to discuss the project 
and to answer any questions related to the study.  For all organisations whose representatives 
expressed an interest in participating, contact was established with the appropriate ethics board 
representative(s), research ethics applications completed and submitted and approved according 
to the requirements of each individual, potential participant facility.   
2.2 Data Collection.   
Four data collection mechanisms were employed at each participating facility as follows: 
1) National Rehabilitation Reporting System (NRS) data reports, 2) retrospective chart review, 3) 
online rehabilitation staff survey, and a 4) brief survey directed to rehabilitation program 
management and distributed by email.  The first two mechanisms focused on adherence to 
Canadian Best Practice Recommendations for post-stroke depression by identifying and 
describing existing practices. The second two approaches focused on the collection of 
information intended to inform our understanding of why identified gaps may exist.    
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2.2.1 NRS Data Reports. 
For each of the inpatient rehabilitation programs recruited to the study, each facility’s 
submissions to the NRS database were used to identity all stroke rehabilitation patients 
discharged over a 6-month period beginning 1st September, 2010.  In addition, the following, 
anonymous patient information for this sample was requested from the NRS database by the 
onsite data analyst or stroke coordinator: patient age, gender, date of stroke onset, dates of 
admission to and discharge from the rehabilitation service and Functional Independence Measure 
(FIM™) scores (FIM-total™, FIM-motor™, FIM-cog™) at both admission and discharge.   
The FIMTM provides an assessment of physical and cognitive disability in terms of burden 
of care.96  The FIMTM is a composite measure consisting of 18 items assessing 6 areas of 
function (self-care, sphincter control, mobility, locomotion, communication and social 
cognition).  Scores for items range from a rating of 0 (total assistance required) to 7 (total 
independence).  Total scores range from 18 to 126.  Subscale scores also may be produced for 
the physical (13 items) and cognitive (5 items) domains (Linacre et al. 1994).  The FIMTM has 
been reported to be both reliable and valid when used in populations of individuals with stroke.97  
For the purposes of the present study, admission FIMTM scores were used as a surrogate for the 
severity of initial functional deficit attributable to the stroke event.98   
Prior to being released to the research project, all NRS reports were anonymised by the 
onsite data analyst and patient records assigned study identification numbers provided by the 
researcher (K.L.S.).  Master lists connecting hospital or patient chart identification numbers to 
study identification numbers were maintained at each participating facility in a secured location 
until all data were entered into the centralised study database held at Parkwood Hospital, 
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London, Ontario, Canada.  Once data entry was complete, participating facilities were contacted 
by the researcher (K.L.S.) with instructions to destroy existing master lists.   
2.2.2  Retrospective Chart Review.  
For the purposes of the current practice audit, the Canadian Best Practice 
Recommendations86, 87 were operationalized by identifying three simple statements that represent 
the basic action elements of the recommendations pertaining to PSD: 1) All patients with stroke 
should be screened for depression using a validated tool, 2) Patients identified as at risk for 
depression through screening should be referred to a psychiatrist or psychologist for further 
assessment and diagnosis, and 3) Patients diagnosed with a depressive disorder should be given a 
trial of antidepressant medication, if no contraindication exists.  Based on previous retrospective 
chart reviews undertaken at Parkwood Hospital, it was established, in consultation with the 
medical director (Dr. Robert Teasell), that the expectation for these elements (i.e. formal 
screening, referral for consultation, assessment and prescription of a medication) to be recorded 
in a patient chart was reasonable.  Information abstracted from the health records, therefore, 
included performance of formal screening, standardised tools used for this task, results of 
screening, psychiatric or psychological consultations (requested/performed), formal diagnoses 
with regard to mood or psychological distress made during the inpatient stay, recommendations 
for treatment, and antidepressant treatment provided at admission and at discharge from inpatient 
rehabilitation.   
Occurrences in the chart of noted depressive symptomatology or references to the patient 
as “depressed” also were recorded. These data were intended to provide another source of 
information to enrich our understanding of the current practice culture in terms of awareness and 
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treatment of PSD.  Notations regarding depressive symptomatology were not considered a 
substitute for formal screening, assessment and diagnosis.  
At each participating institution, the health record for each patient identified in the NRS 
report was requested for review in either paper or electronic form, depending upon the standard 
used for maintenance of health records at each facility.  All health records were reviewed on site 
by a single researcher who has extensive experience in data abstraction processes and procedures 
(K.L.S.).  Accuracy of the abstraction process was checked on a sample of charts (n=20) at 
Parkwood Hospital by comparing abstraction results with a chart review conducted by a summer 
student employed to complete a series of abstractions for several other projects.  There were no 
discrepancies noted between the two reviewers.  In addition, following chart review, the 
researcher retained access to the charts for a period of up to one year, so that any discrepancies 
or inconsistencies found within the data during data entry could by clarified by consulting the 
original data source. The data abstraction form used to complete the retrospective chart review is 
provided in Appendix 1.  
Information regarding patient age, gender, severity of functional deficit, previous stroke 
and history of previous episodes of depression or other mood disorders addresses the presence or 
absence of some of the most salient risk factors for depression identified in current research 
literature.99, 100  Information addressing known risk factors for depression collected through both 
the NRS database and retrospective chart review was used to address study objectives by 
informing our understanding of current assessment and treatment practices for post-stroke 
depression.   
Best Practices for Post Stroke Depression       26 
 
 
 
2.2.3  Staff Survey  
A short anonymous, online survey was used to identify issues in current practice, attitudes 
toward PSD and barriers to its identification and treatment, as experienced at the level of the 
healthcare practitioner.  This survey, based upon the previous work of Hart and Morris92 on the 
topic of adherence to best practice guidelines for assessment and treatment of post-stroke 
depression, was used with the consent of the original authors.101  The survey consisted of a series 
of questions in five areas:  1) professional background information (3 questions), 2) knowledge 
of and access to the Canadian Best Practice Recommendations for Stroke Care (3 questions), 3) 
information about the respondent’s rehabilitation unit specific to management of depression (7 
questions), 4) views about screening for depression (20 questions) and 5) a single question 
regarding the relative importance of observed symptoms of depression in terms of initiating 
formal screening.  In the first three sections of the survey, the item response format used was 
primarily multiple choice with limited open-ended options to provide clarification as required 
(e.g. “other – please specify”).  Items addressing opinions about screening and assessment for 
PSD each were rated on a scale of 1to 7, where 1 represented “strongly disagree” and 7 
represented “strongly agree”.   Ten of the 20 items were worded in a negative direction in order 
to reduce possible response bias.  Completion of the final question asked that the respondent rate 
each symptom of depression on a scale from 1 to 5 in terms of how great an influence that 
symptom would have on the decision to screen for the presence of PSD, where 1 represented 
“very likely to make me consider screening” and 5 represented “very unlikely to make me 
consider screening”.   The survey was made available to all respondents via the online survey 
utility, Survey Monkey (www.surveymonkey.com) and required approximately 10 minutes to 
complete. A copy of the survey as it appeared online is provided in Appendix 2.  
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All rehabilitation staff involved in patient care (i.e., nurses, all therapists, therapy assistants 
or aides, social workers, physiatrists, etc.) was invited to complete the survey through email.  
Letters of information and consent, as well as debriefing information, were provided to all 
rehabilitation staff via email (see Appendix 3).  Invitations to participate were followed by 
reminder invitations two weeks after the initial invitation was offered.  Survey access remained 
open for all invited respondents for a maximum of 60 days per facility, at which time a 
debriefing letter explaining the study and its purpose was sent to all staff that had been invited to 
respond to the survey.  All email invitations, reminders and debriefing notices were distributed to 
staff by the rehabilitation coordinator on site at each facility using her or his own distribution 
lists to which the researcher had no access.  In this way, there was no direct contact established 
between the researcher and clinical staff and no single respondent at any participating facility 
could be identified.   In order to promote completion by as many respondents as possible, each 
site was also provided with the option to complete a pen-and-paper version of the survey, at the 
time of the site visit.     
2.2.4 Rehabilitation Management Questionnaire 
It is recognized that the presence of care gaps can be explained, in part, by issues at the 
level of the healthcare provider or organisation.  A brief, email-administered questionnaire was 
undertaken to identify current practices, facilitators and barriers to the use of best practice at the 
level of the organisation and to provide important context for all data collected.  Rehabilitation 
managers were asked to provide a brief description of their service and to identify whether or not 
an official protocol or strategy for the identification and management of PSD was in place at 
their facility.  Questions addressed topics such as familiarity and use of the best practice 
recommendations, in addition to perceived barriers and facilitators associated with the 
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development and implementation of a protocol for PSD within the rehabilitation unit.  
Completion of the questionnaire required approximately 10 minutes.  Questionnaires were sent 
to each rehabilitation coordinator or district stroke coordinator, as appropriate, at each 
participating facility as soon as possible after data collection was complete in order to capture 
organisational practices and policies concurrent with staff survey responses.  The management 
questionnaire is provided in Appendix 4.   
2.3  Data Analyses 
2.3.1 Description of Participant Programs and Identified Patient Populations 
For each rehabilitation program that agreed to participate, information describing the 
location, type of program (general vs. specialized), and size of unit (number of beds) was 
summarized.  In addition, the patient population, whose records were identified for inclusion at 
each facility, is described in terms of mean (± standard deviation/S.D.) age, length of stay, and 
both admission FIMTM and discharge FIMTM (FIM-totalTM, FIM-motorTM, FIM-cogTM) scores.  
Proportions were calculated for categorical descriptors such as sex, previous stroke and 
presence/absence of history of psychiatric illness or depression.  Between facility differences 
were examined using multivariate analyses of variance (MANOVA) for continuous data and chi-
square analyses (Pearson), as appropriate. The alpha level of statistical significance for these 
analyses and all others used in the study was set at p < 0.05. P-values between 0.05 and 0.10 
were labelled as “approaching significance”. 
2.3.2  Adherence to Guidelines  
To address the primary study objective, the overall rate of reported adherence within each 
participant program was calculated for 1) formal screening, 2) referral for assessment by a 
mental healthcare professional and 3) treatment with an antidepressant.  A between-facilities 
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comparison of overall adherence rates was performed using the Pearson chi-square statistic.  
However, it was recognized that best practices for PSD cannot be defined by adherence to a 
single element.  Adherence in one area of the recommendations was not necessarily related to 
adherence in another area.  Therefore, the primary outcomes of interest are more accurately 
represented by the following four conditional probabilities, which were calculated both overall 
and per facility:  1) the proportion of patients who were screened; 2) the proportion of patients 
screened (in item 1) who were referred for assessment; 3) the proportion of (2) who were 
diagnosed with depression; and 4) the proportion of (3) who received treatment with an 
antidepressant at the time of discharge from rehabilitation.    
2.3.3 Examining Treatment Patterns (secondary objective)  
In a preliminary analysis, between-group differences were examined for patients treated 
with an antidepressant at the time of discharge from rehabilitation and those who were not for all 
variables identified as risk factors for PSD, as well as elements indicative of current clinical 
practice.  Data designated as risk factor variables were collected from patient records or from the 
NRS database reports and included history of stroke, previous history of psychiatric illness, age, 
sex and severity of impairment at admission.  Data considered representative of current clinical 
practice were gathered from the chart review and included the presence/absence of notations 
regarding depressive symptomatology, whether the patient had been formally screened or 
assessed for PSD, and whether or not the patient was treated with an antidepressant at the time of 
admission.  Between-group differences were assessed using either analysis of variance 
(ANOVA) or chi-square (Pearson), for continuous and categorical variables, respectively.   
Multiple logistic regression using the backward stepwise method was conducted to build 
an explanatory model for antidepressant treatment in rehabilitation.  Variables identified as 
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having a significant, or nearly significant (p<0.1), association with treatment through the 
preliminary, between-group analyses were selected for inclusion in the model.  Wald χ2 statistic 
and associated significance, odds ratio (OR) and 95% confidence intervals (CI) are reported for 
all variables included in the final model.  The accuracy of the model in terms of prediction of 
treatment is presented. Given the presence of both continuous and categorical variables used in 
the regression model goodness-of-fit was assessed using the Hosmer-Lemeshow test.102  Amount 
of variance in the dependent variable (treatment at discharge) accounted for by the final model 
was assessed using the Nagelkerke pseudo-R2 statistic.102   
2.3.4 Analyses of Supplemental Information – Staff and Rehabilitation Management 
Surveys (secondary objective) 
Descriptive, summary information gathered from the first three sections of the staff survey 
(professional background, knowledge of and access to the Canadian Best Practice 
Recommendations, and current practices around the identification and treatment of PSD) are 
expressed as proportions of the total number of survey respondents.  For the section addressing 
views or opinions regarding the identification and treatment of PSD, responses to individual 
items were explored based on summary values calculated for each item.  Items worded in a 
negative direction were reverse coded to create a consistent scoring metric for all items.  Both 
median (interquartile range/IQR) and mean (± S.D.) values were calculated for each item.  As 
per Hart and Morris, mean item scores of 4 were considered neutral.92  Those items with a mean 
score above 4 were considered reflective of a facilitating influence for best practice for PSD, 
while those items with mean scores below 4 were considered reflective of a negative influence or 
barrier.92   Similarly, median ratings for each symptom of depression were examined to 
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determine which, if any, symptoms were most likely to trigger formal screening from the point 
of view of the survey respondents.   
The rehabilitation management survey provided quantitative estimates of the proportion of 
facility participants who reported compliance with the Canadian Best Practice Guidelines at the 
program level.  Responses from program management were reviewed to identify commonly 
reported barriers and facilitators to implementation of or adherence to best practice 
recommendations.   
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Chapter 3 
3. Results 
3.1 Participant Rehabilitation Programs and Patient Population 
A total of 7 inpatient rehabilitation programs in Southwestern Ontario (SWO) providing 
services to individuals with stroke were identified for possible inclusion in the present study.  
Contact information was obtained for all facilities and invitations to participate in the research 
project were issued as per study protocol.  Representatives from five programs agreed to 
participate. Research ethics were obtained for all five sites.  A total of 294 patient charts were 
identified as representing individuals discharged from inpatient rehabilitation over the 6-month 
study period.  Descriptions of the facilities included in the present study and number of patient 
charts identified at each one are provided in Table 3.   
Table 3. Participant Inpatient Stroke Rehabilitation Programs.   
 
Facility Location Unit Type Number of beds Study Na 
St. Joseph’s Healthcare 
London, Parkwood 
Hospital Site 
London Specialized 
stroke unit 
30 118 
Chatham-Kent Health 
Alliance 
Chatham General 32 (19 
stroke/orthopaedic) 
39 
Huron Perth Health 
Alliance 
Stratford General 14 28 
Grey-Bruce Health 
Services 
Owen Sound General 16 48 
Windsor Regional 
Hospital 
Windsor General 52 (20 stroke-
dedicated) 
61 
anumber of patient records identified as discharged over the specified 6-month period and 
included in the study 
 
Descriptions of the patients whose records were included from each rehabilitation program 
are provided in Table 4.  Overall, there were no between-program patient-level differences in 
terms of sex, pre-admission history of psychiatric illness or depression, FIM-motorTM scores or 
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FIM-totalTM scores on admission to rehabilitation.  However, between-program analyses 
revealed that there was a significantly greater proportion of patients admitted with previous 
stroke at the Huron-Perth facility than at any of the other participant facilities (χ2=0.41, df=4, 
p=0.41).  In addition, there were significant between-program differences demonstrated in terms 
of patient age (F=2.74, df=4, p=0.029), admission FIM-cog™ scores (F=13.96, df=4, p<0.0001), 
length of stay (F=3.55, df=4, p=0.008), and all discharge FIM™ scores, both total and subscale 
scores (FIM-total:  F=3.16, df=4, p=0.015; FIM-motor: F=3.48, df=4, p=0.009; FIM-cog: 
F=3.27, df=4, p=0.012).  Results of pairwise comparisons are noted in Table 4. 
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Table 4.  Patient Characteristics by Program. 
 
Patient 
Characteristics 
Parkwood 
Hospital 
Chatham-
Kent 
Health 
Alliance 
Huron-
Perth 
Health 
Alliance 
Grey-
Bruce 
Health 
Services 
Windsor 
Regional 
Hospital 
Number of participants 118 39 28 48 61 
Sex (F)a 48.3% 48.7% 67.9% 41.7% 47.5% 
Previous stroke (Y) 31.9% 30.8% 60.7% 29.2% 31.7% 
Psychiatric History (Y) 26.3% 20.5% 10.7% 25% 11.5% 
History of Depression 
(Y)  
18.6% 12.8% 7.1% 16.7% 11.5% 
Age at Admission 67.74b 
(15.79) 
74.9 
(12.68) 
74.75 
(15.1) 
70.93 
(10.37) 
70.64 
(12.77) 
Length of Stay – days 
(LOS) 
33.74 
(16.61) 
27.23 
(20.62) 
33.61 
(23.17)  
26.85 
(23.24) 
41.82c 
(31.72) 
Admission FIM-total™ 75.16 
(23.95) 
76.49 
(22.37) 
69.46 
(26.48) 
72.22 
(21.26) 
68.2 (30) 
Admission FIM-motor™ 49.07 
(21.1) 
50.31 
(17.31) 
43.64 
(22.77) 
47.66 
(17.82) 
50.98 
(23.76) 
Admission FIM-cog™ 26.09 
(6.17) 
26.18 
(8.34) 
25.82 
(7.01) 
24.56 
(8.81) 
17.29d 
(9.27) 
Discharge  FIM-total™ 99.91e 
(22.67) 
92.38 
(31.92) 
86.71 
(32.51) 
100.39e 
(16.56) 
88.48 
(29.6) 
Discharge  FIM-motor™ 70.97f 
(20.18) 
64.44 
(23.64) 
58.75 
(27.39)  
73.54f 
(11.56) 
63.67 
(22.9) 
Discharge  FIM-cog™  28.95 
(4.88) 
27.95 
(9.63) 
27.96 
(6.99) 
26.85 
(7.32) 
24.82g 
(8.95) 
acategorical variables are reported as a proportion of the total number of patients 
identified at that institution. Continuous variables are reported as mean (±SD).  
bPatients admitted to Parkwood Hospital were significantly younger than those at either 
Chatham-Kent (p=0.006), or Huron-Perth (p=0.019) rehabilitation programs.  
cPatient length of stay at Windsor Regional Hospital was significantly longer than 
Parkwood Hospital (p=0.028), Chatham-Kent (p=0.002) and Grey-Bruce (p=0.001). 
dPatients admitted to Windsor Regional Hospital had significantly lower FIM-cogTM scores 
than at any other program (p<0.0001). 
eDischarge FIM-totalTM scores were significantly higher at i) Parkwood (p=0.016 and 
p=0.008) and Grey-Bruce (p=0.032 and p=0.027) than at either Huron-Perth or 
Windsor, respectively.    
fDischarge FIM-motorTM scores were significantly higher at i) Parkwood (p=0.006 and 
p=0.035) and Grey-Bruce (p=0.005 and p=0.024) than at either Huron-Perth or 
Windsor, respectively.  
gFIM-cogTM scores at discharge were significantly lower at Windsor Regional hospital than 
at either Parkwood (p<0.0001) or Chatham-Kent (p=0.008).    
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3.2  Adherence to Guidelines 
Overall, 41 patients (41/294 = 13.9%) were screened using a standardized screening tool 
for the possible presence of depression, 36 (12.2%) were referred for psychiatric assessment, 13 
(4.4%) were diagnosed with depression during their inpatient stay, and 113 (38.4%) were treated 
with an antidepressant at the time of discharge from rehabilitation.  Chi-square analyses 
demonstrated significant differences between institutions for rates of screening (χ2=15.4, df=4, 
p=0.004) and referral for assessment (χ2=49.887, df=4, p<0.0001).  It should be noted that, for 
both assessment referrals and diagnosis of depression, more than 20% of cells had expected cell 
counts of less than 5 and observed cell counts of less than 1.  Therefore, the results of these 
analyses may not be valid.  Rates of treatment with an antidepressant did not vary significantly 
between institutions (χ2=1.22, df=4, p=0.88).   Overall rates of screening, referral, diagnosis and 
treatment by institution are provided in Table 5.   
Table 5.  Overall Adherence to Best Practice Recommendations by Programa. 
 
Elements of Best 
Practice 
Parkwood 
Hospital 
Chatham-
Kent 
Health 
Alliance 
Huron-
Perth 
Health 
Alliance 
Grey-
Bruce 
Health 
Services 
Windsor 
Regional 
Hospital 
Screened for PSD 25 (21.2) 3 (7.7) 1 (3.6) 1 (2.1) 11 (18) 
Referred for Formal 
Assessment  
9 (7.6) 4 (10.3) 0 0 23 (37.7) 
Diagnosis of Depression 
Recorded 
4 (3.4) 2 (5.1) 0 0 7 (11.5) 
Treatment with 
Antidepressant 
(Discharge) 
47 (39.8) 17 (43.6) 11 (39.3) 16 (33.3) 22 (36.1) 
aRecorded adherence is reported as n (% within institution) 
 
Examination of the four conditional probabilities created to address the primary hypothesis 
revealed that of the 41 patients who were screened formally for depression, 16 (39%) were 
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referred for assessment by a qualified mental healthcare professional.  Of these 16 individuals, 6 
received a diagnosis of depression and 3 were treated with an antidepressant.  It should be noted 
that referral for assessment occurred in only 3 of the 5 participant programs; Parkwood Hospital 
(n=4), Chatham-Kent (n=1) and Windsor Regional Hospital (n=11).  A formal diagnosis of 
depression was recorded in patient records identified at the Parkwood (n=3) and Windsor (n=3) 
sites only.  Patients diagnosed with depression received treatment with an antidepressant at a 
single facility (n=3).  Given the presence of a large number of expected and observed cell counts 
≤ 5, it was not possible to conduct a reliable statistical examination of between-institution 
performance for each of the established conditions.   
3.3   Examining Treatment Patterns 
An examination of data gathered for those patients who were treated with an antidepressant 
vs. those who were not demonstrated significant between-group differences for the following 
categorical variables: pre-admission history of psychiatric illness (χ2=50.232, df=1, p<0.0001), 
notation of depressive symptomatology in the patient record (χ2=17.51, df=1, p<0.0001), formal 
screening for depression (χ2=4.67, df=1, p=0.03), referral for assessment (χ2=3.57, df=1, 
p=0.06), and use of an antidepressant at the time of admission to rehabilitation (χ2=179.08, df=1, 
p<0.0001).  Although the recorded diagnosis of depression was significantly associated with 
treatment, this may not have been a valid result given the presence of expected cell counts of less 
than 1.  Therefore, this variable was not included in the regression analysis.  In addition, there 
were significant between-group differences demonstrated for both FIM-motor™ (F=30.78, df=1, 
p<0.0001) and FIM-cog™ (F=212.03, df=1, p=0.08) scores at admission to rehabilitation.  The 
results of between-group analyses for all known risk factors and current practice variables are 
presented in Table 6.    
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Table 6.  Risk Factors and Current Practice Variables: Treated Vs. Untreated 
Groupsa. 
 
 Treated with 
Antidepressants 
(n=113) 
Not Treated 
with 
Antidepressants 
(n=181) 
Test 
Statistic 
p-value 
Known Risk Factors for PSD 
Age at Admissionb  70.08 (13.37) 70.68 (14.65) F=0.13 0.72 
Admission FIM-motor™ 40 (19.64) 53.4 (20.37) F=30.78 <0.0001 
Admission FIM-cog™ 22.86 (9.1) 24.61 (8.04) F=2.96 <0.086 
Sex (F)b 57 (50.4) 87 (48.1) χ2=0.16 0.39 
Previous stroke 43 (38.4) 56 (31.3) χ2=1.55 0.21 
Pre-Admission History of 
Psychiatric Illness 
44  18 χ2=35.141 <0.0001 
Practice Indicators 
Observations/symptoms 
of depression noted in 
chart  
77 (68.1) 78 (43.1) χ2=17.51 <0.0001 
Screened for depression 22 (19.5) 19 (10.5) χ2= 4.67 0.03 
Referred for assessment 19 (16.8) 17 (9.4) χ2= 3.57 0.06 
Diagnosed with 
depression 
9 (8.0) 4 (2.2) χ2= 5.6 0.06c 
Treated with 
antidepressant at time of 
admission 
81 (71.7) 0 (0.0) χ2= 179.08 <0.0001 
aAt discharge from rehabilitation; bContinuous variables are reported as 
mean(±sd).Categorical variables are reported as n(%); cExpected cell count <1, therefore, 
results may not be valid.   
 
Based on the results of the preliminary analyses, the following seven variables were 
included in the regression model: admission FIM-motor scores, admission FIM-cog scores, 
history of psychiatric illness, charted symptoms of depression, formal screening, referral for 
psychiatric assessment and recorded treatment with antidepressants on admission.  Although the 
association between diagnosis and treatment approached statistical significance, diagnosis of 
depression was not included in the regression given that this may not be a valid result based on 
low expected cell counts within the chi-square analysis.  In addition,  given that there were no 
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significant differences between institutions in terms of proportions of patients receiving 
treatment with antidepressant medications at the time of discharge from rehabilitation (χ2=1.22, 
df=4, p=0.875), a single regression analysis was conducted to address current treatment patterns 
across the region.   
Inclusion of seven possible explanatory variables for the dependent variable, treatment 
with an antidepressant at discharge, resulted in a calculated events-per-variable (EPV) value of 
16, which exceeds the EPV of 10 recommended to minimize bias and produce a valid model 
using stepwise logistic regression techniques.103, 104 Seven variables were, therefore, entered into 
the backward stepwise regression.  The level of significance for inclusion in the final model was 
set to 0.05. 
The model resolved after 5 iterations at which time only 3 variables remained in the model. 
These included admission FIM-motor™, charted symptoms of depression, and treatment with an 
antidepressant at the time of admission. Overall predictive accuracy of the model was 89.1%.  
Results of the Hosmer and Lemeshow Test (χ2=7.23, df=8, p=0.51) indicated that the observed 
outcomes regarding treatment with an antidepressant did not differ significantly from those 
predicted by the model and that the goodness-of-fit was acceptable.  Examination of the 
Nagelkerke-R2 revealed that this model could account for approximately 76% of the variance in 
the dependent variable.  The model is presented in Table 7.   
Table 7.  Results of Logistic Regression: Treatment with Antidepressant at 
Discharge. 
 
 Wald χ2a Sig OR 95% CI 
Admission FIM-motor™ 13.49 <0.0001 0.97 0.94,0.98 
Charted symptoms of depression 8.68 0.003 3.97 1.59,9.94 
Treated with an antidepressant on 
admission 
0.00 0.996 1405205… n/ab 
adf=1; bn/a=not available 
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However, the model produced may not be stable.  The practice indicator of treatment at 
admission contributed no variability to the model insofar as all patients who received treatment 
with an antidepressant at admission were treated with an antidepressant at discharge.  Therefore, 
a second, post hoc, logistic regression was performed, without treatment at admission, to 
determine what other factors may be influencing treatment given that all patients treated with an 
antidepressant at admission continued to be treated with an antidepressant at discharge.   
When the 6 remaining explanatory variables were entered in a backward stepwise 
regression, the model resolved after 4 steps after which the following variables remained:  
admission FIM-motor™ scores, previous history of psychiatric illness and charted symptoms of 
depression.  Overall predictive accuracy of the model was reduced to 70.3%, although results of 
the Hosmer and Lemeshow Test (χ2= 5.87, df=8, p=0.66) demonstrated that the observed 
outcomes regarding treatment with an antidepressant still did not differ significantly from those 
predicted by the model. This indicated that the goodness-of-fit was acceptable.  Examination of 
the Nagelkerke-R2 revealed that this model could account for only 28% of the variance in the 
dependent variable.  The results of the post hoc regression analysis are presented in Table 8. 
Table 8.  Results of Post Hoc Logistic Regression: Treatment with Antidepressant 
at Discharge. 
 
 Wald χ2a Sig OR 95% CI 
Admission FIM-motor™ 21.13 <0.0001 0.97 0.97,0.98 
History of psychiatric illness 25.75 <0.0001 5.64 2.89,10.99 
Charted symptoms of depression 5.95 0.015 1.97 1.14,3.39 
adf=1 
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3.4 Staff and Rehabilitation Management Surveys  
3.4.1 Staff Survey 
Based on the staffing information provided by rehabilitation managers at all participant 
programs, the total number of potential survey respondents was 189.  Seventy-two individuals 
responded by the time that the survey site was closed (response rate = 38.1%).  However, not all 
of the respondents chose to provide responses to all items. Given that items were to be 
considered individually and no summary scores produced, it was decided that, in order to 
maintain the maximum amount of contributed information for each item, list-wise exclusions of 
missing information would not be performed. The number of responses received are reported for 
individual items and proportions calculated as a percentage of the total number of responses for 
that item.   
Overall, the rehabilitation professionals who chose to respond to the survey invitation were 
experienced healthcare practitioners.  The majority of respondents (83.3%) reported having more 
than 10 years of experience in their profession; 31.9% reported 10 to 20 years and 51.4% 
reported more than 20 years of experience.  A summary of survey respondents by profession is 
provided in Table 9. 
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Table 9.  Survey Respondents (n=72) 
 
Profession 
N Percent 
Nurse, Nurse Practitioner (NP) 36 50 
Physiotherapist/Physiotherapy Aide or Assistant  
(PT or PTA) 
10 13.9 
Occupational Therapist/Occupational Therapy Aide 
or Assistant (OT or OTA) 
8 11.1 
Social Worker 5 6.9 
Speech-Language Pathologist or Therapist (SLP) 4 5.6 
Psychologist, Psychometrist, Psychiatrist 3 4.2 
Attending Physician, Physiatrist, Neurologist 3 4.2 
Recreation Therapist (RT) 2 2.8 
Dietician 1 1.4 
 
 
Although 76.4% of respondents reported having access to the best practice 
recommendations, 44.4% had not read them and an additional 31.9% had read only the summary 
version of the recommendations.  Less than one-third (30.8%) of respondents were aware of the 
specific recommendations pertaining to PSD, while an additional 38.9% reported being 
“somewhat aware”.  A summary of survey responses pertaining to perceived screening and 
assessment practices is presented in Table 10.   
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Table 10. Summary of Screening and Assessment Practices 
 
 N
a Response Options Response 
Count 
Percent  
Screening a part of routine 
assessment?  
66 Yes 32 48.48 
No 6 9.1 
Don’t Know 3 4.54 
Yes, but not all patients 25 37.87 
How often is a formal screening 
tool used? 
56 0-20% of the time 10 17.86 
21-40% 13 23.21 
41-60% 12 21.42 
61-80% 0 0.0 
81-100% 21 37.5 
Do you know which tool is used for 
formal screening?  
66 Yes 38 57.58 
No 28 42.42 
Which screening tools are used?b 38 HADS 21 46.67 
GDS 19 42.22 
PHQ-2 2 4.44 
BDI 1 2.22 
VAMS 2 4.44 
Who screens for depression on your 
unit?c 
64 Nurse/NP 39 30.95 
Physiotherapist 1 0.79 
Psychologist or 
Psychiatrist 
19 15.08 
Social Worker 36 28.57 
SLP 3 2.38 
Doctor/physiatrist 22 17.46 
Occupational Therapist 4 3.17 
Don’t know 2 1.59 
Do you have access to a 
psychologist or psychiatrist?  
65 Yes 53 81.54 
No 10 15.38 
Don’t know 2 3.01 
How is depression assessed?  66 Clinical Observation 15 22.73 
Depression Questionnaire 21 31.82 
Clinical Interview 8 12.5 
A mixture 22 34.38 
aNumber of responses for this item; bHADS=Hospital Anxiety and Depression Scale, 
GDS=Geriatric Depression Scale, PHQ-2 = Patient Health Questionnaire 2-item version, 
BDI=Beck Depression Inventory VAMS=Visual Analog Mood Scale.  Please note that 
respondents could indicate more than one screening tool used; 45 responses were given by 
38 individuals; cRespondent could indicate more than one discipline that screens for 
depression resulting in 126 total responses provided by 64 individuals.     
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A total of 54 respondents provided an estimate of the number of patients screened formally 
for PSD within their respective programs in a one-month period.  These estimates ranged from 0 
(35.19%) to 50 (1.85%).  The most frequent estimates were for 0 (n=19, 35.19%), 2 (n=10, 
18.52%) and 3 (n=8, 14.81%) patients screened per month.    
For the section of the survey addressing the views or opinions of health care professions 
regarding the identification and treatment of PSD, responses to individual items were explored as 
potential facilitators or barriers to best practice based on mean values calculated for each item.  
Item level results are provided in Table 11.   
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Table 11.  Staff Opinions Regarding the Identification and Treatment of PSD 
 
Itema 
Mean  
(SD) 
Median 
(IQR) 
Screening patients for depression after their stroke is important. 6.52 (0.94) 7 (1) 
My professional colleagues think I should screen patients for 
depression after their stroke (or ask for them to be screened). 
4.85 (1.78) 5 (3) 
Screening patients for depression (or asking for them to be 
screened) after their stroke is expected of me. 
4.39 (1.9)   4 (3) 
I feel comfortable screening patients for depression. 4.26 (2.08) 5 (4) 
I have adequate skills and training to screen patients for 
depression (or to know when to ask for screening). 
4.6 (1.97) 5 (3) 
Whether or not I screen patients (or ask for them to be screened) 
for depression is my decision. 
3.41 (2.04) 3 (4) 
Screening for depression (or asking for someone to be screened) 
is part of my role. 
5.8 (1.58) 6 (2) 
Most screening questionnaires are suitable for use with stroke 
patients (e.g. those with communication difficulties, cognitive 
impairment, etc). 
4.58 (1.44) 4 (2) 
Time pressures do not make it less likely that I screen patients 
(or ask for someone to be screened) for depression. 
4.77 (1.88) 5 (2) 
Screening patients for depression can reduce uncertainty about 
whether or not they have depression. 
5.37 (1.33) 6 (2) 
Screening questionnaires for assessing depression are clinically 
useful. 
5.41 (1.2) 5 (1) 
Screening for depression is more effectively achieved through the 
use of screening questionnaires than clinical observation.   
3.92 (1.56) 4 (2) 
Understanding that a patient is depressed by screening helps me 
to engage them in rehabilitation. 
5.3 (1.16) 5 (2) 
Recognising symptoms of post stroke depression is not difficult. 4.34 (1.38) 5 (2) 
It is not difficult to treat post stroke depression once a diagnosis 
is made. 
5.26 (1.28) 5 (2) 
Discussing depression treatment options with patients is not 
difficult and is not likely to upset them.  
4.47 (1.48) 4 (3) 
Most patients do not feel that a diagnosis of depression is an 
indication of personal weakness. 
3.76 (1.4) 4 (2) 
Antidepressant medications are effective for treatment of post-
stroke depression. 
5.97 (0.98) 6 (1) 
The presence of communication issues does not prevent you from 
screening an individual for depression.  
4.33 (1.61) 4 (3) 
The presence of cognitive issues does not prevent you from 
screening an individual for depression.  
4.24 (1.57) 4 (3) 
aScored on a scale of 1-7, where 1 represents “strongly disagree” and  7 represents 
“strongly agree”.  Items originally worded in a negative direction were reversed for scoring. 
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For seven items, mean scores were 5 or more and were considered representative of 
facilitating influences.  Respondents felt that screening is important and indicated that they 
consider it to be part of their current role. Screening was viewed as a clinically useful activity 
that could reduce uncertainty and help the clinician to engage patients in rehabilitation.  In 
addition, pharmacotherapy was viewed as an effective approach to management for PSD.   
Potential barriers to best practice included in the survey were time constraints, the presence 
of cognitive or communication impairments in patients following stroke, anticipated negative 
opinions or reactions from patients regarding depression, feeling uncomfortable talking to 
patients about depression, perceived lack of skills or education, and believing screening tools to 
be ineffective or unsuitable.  These items received neutral rather than the expected low (<4) 
summary ratings associated with a negative influence. Only one item had a mean score indicative 
of a negative influence; staff did not feel that the decision to screen patients was under their 
control.   
Symptoms rated as very likely to trigger a formal screening for depression included apathy, 
hopelessness, thoughts of death, suicidal thoughts, lack of motivation, reports of feeling 
worthless and loss of interest. Overall, there were no symptoms of depression that were rated as 
unlikely to prompt formal screening.  Only two symptoms were rated as neither likely nor 
unlikely to make one consider screening. These included poor concentration and distractibility.  
The summary ratings for all symptoms are reported in Table 12.   
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Table 12. Importance of Symptoms in Triggering Screening for Depression  
 
Itema 
Median 
(IQR)b 
1. Emotional lability 2 (2) 
2. Apathy 1 (1) 
3. Tension 2 (1) 
4. Poor concentration 3 (1) 
5. Reports of feeling guilty 2 (2) 
6. Hopelessness 1 (0) 
7. Agitation 2 (1) 
8. Early waking or insomnia  2 (1) 
9. Thoughts of death 1 (0) 
10. Suicidal thoughts 1 (0) 
11. Lack of motivation 1 (1) 
12. Sleepiness  2 (2) 
13. Reports of feeling worthless 1 (0) 
14. Loss of energy 2 (2) 
15. Loss of interest  1 (1) 
16. Weight gain or loss 2 (1) 
17. Distractibility 3 (1) 
aScored on a scale of 1-5, where 1 represents  
“very likely to make me consider screening”.  
bIQR=Interquartile Range. 
 
 
3.4.2 Rehabilitation Management Survey 
Rehabilitation managers of all five participant inpatient programs (n=5) reported 
familiarity with the Canadian Best Practice Recommendations for Stroke Care.  Three of five 
managers reported having an official protocol or strategy in place for the identification and 
management of PSD, although in one case, the protocol was reported as “not yet formalized”.   
Of the two who identified using protocols, only one included the three steps of best practice as 
operationalized within the current study (i.e., screening, referral for formal assessment and 
diagnosis, and treatment with a trial of an antidepressant agent).  Limited resources and lack of 
access to psychological and/or psychiatric services were reported as barriers to referral for 
assessment and diagnosis at the other facility.  A summary of responses from rehabilitation 
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managers regarding best practice protocols, including identified facilitators and barriers to the 
development of a best practice protocol for PSD, is provided in Table 13.   
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Table 13.  Summary Results of Rehabilitation Management Survey: 
Implementation of Recommendations 
 
 Parkwood 
Hospital 
Chatham-
Kent 
Health 
Alliance 
Huron-
Perth 
Health 
Alliance 
Grey-
Bruce 
Health 
Services 
Windsor 
Regional 
Hospital 
1. Official protocol or 
strategy? 
Yes No No Yes* No 
2. Familiar with the 
Canadian Best Practices 
Recommendations? 
Yes Yes Yes Yes Yes 
3. Specific to stroke?  N/A No Yes  N/A N/A 
4. Were they used in the 
development of your 
protocol?** 
Yes  N/A N/A No Yes 
5. Are the best practice 
recommendations 
available to staff on your 
unit?  
N/A Yes Yes N/A N/A 
6. Has PSD been identified 
as a problem on your 
unit? 
N/A Yes Yes N/A N/A 
Programs with no-protocols 
1. Identified barriers and 
challenges to possible 
protocol development  
Constant leadership and staff changes; program changes are 
slow; resource limitations – PSD is not a priority; not enough 
social work support, need more training and information 
available to management, clinical staff and patients about 
PSD; lack of acceptance regarding the use of antidepressants 
(patients don’t like taking them) 
2. Factors perceived as 
potentially helpful in 
protocol development 
Access to protocols used elsewhere and specific 
recommendations for management of depression; 
standardized rehabilitation orders that include screening; a 
quick and easy screening tool; simple interventions; 
recommendations from pharmacists; available 
information/handouts regarding depression.  
Programs with protocols 
1. Factors that were 
perceived as helpful in 
protocol development 
Ongoing team education; available assistance from research 
staff; getting screening as part of a standardised admission 
package – without it, screening was just another piece of 
paper to keep track of and complete; setting up quality 
assurance checks 
2. Identified 
barriers/challenges 
encountered  
Difficult to change team behaviour; ensuring that all patients 
are screened; no resources are available for psychological or 
psychiatric services; difficult to ensure follow-up with psych 
* Official strategy reported as “not yet formalized”; ** Note:  Managers completed either 
section A or B of the survey depending on whether or not there was a protocol for PSD used 
within their program.  Responses to questions that did not appear in the portion of the 
survey completed by a given institution will be reported as N/A 
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Chapter 4 
4. Discussion 
The use of formal screening is associated with improved detection and treatment of 
depression.89, 90  However, depression following stroke may remain under-diagnosed and under-
treated.  Results of previous studies, originating in both the UK and the USA, demonstrated that 
rates of systematic, formal screening for depression following stroke in those countries were 
approximately 50% at the time of their respective audits.91, 93   In the present retrospective 
practice audit, it was hypothesised that the frequency of formal screening for depression in 
inpatient rehabilitation settings would not reach 50%.  Indeed, findings from this study showed 
that there was recorded evidence of formal screening for depression in the audited medical 
records of only 13.9% of individuals with stroke admitted for inpatient rehabilitation services at 
5 facilities in Southwestern Ontario over a 6-month period.  The reasons why screening rates in 
Southwestern Ontario fell far short of those recorded in the USA or the UK are unknown and a 
thorough examination of differences in health policy and/or provision of rehabilitation services 
across countries is beyond the scope of the present study.   
Although 12.2% of patients were referred for consultation with a psychologist or 
psychiatrist overall, only 16 of 41 (39%) individuals who had been formally screened for 
depression were referred for further assessment and only 6 patients in total received a diagnosis 
of depression following formal screening and assessment.  In spite of very low recorded rates of 
both screening and assessment, more than one-third of patients in all participant rehabilitation 
programs received pharmacotherapy for depression (range: 33.3% - 43.6%), as hypothesised a 
priori.  In fact, examination of the recommendations as a conditional sequence of actions based 
on the best practice recommendations revealed that only 3 of the 113 patients receiving 
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pharmacotherapy for depression were treated subsequent to formal screening, assessment and 
diagnosis of depression.    
At first glance, the proportion of patients who were treated with depression may seem an 
encouraging result.  After all, the proportion of individuals treated appears to approximate the 
proportion of individuals who will experience depression following a stroke event.14  This is, 
however, a lifetime estimate of prevalence that does not take into account either the natural 
history of PSD or the time between the stroke event and initiation of treatment.  Bour et al.28 
reported the cumulative incidence of PSD to be 18.8% at 1-month, 23.1% at 3-months and 
26.7% at 6-months post stroke. In the present sample, mean time between the stroke event and 
admission to rehabilitation was approximately 25 days.  Eighty percent of all patients were 
admitted within 21 days of the index stroke event.  In addition, mean time from stroke onset to 
discharge from rehabilitation was approximately 56 days and 90% of all patients were 
discharged by 3 months.  Therefore, the anticipated incidence of PSD during the timeframe of 
inpatient rehabilitation within the present audit ranges from approximately 19% to 23%, which is 
far lower than the documented rates of treatment.  Given that published estimates of incidence 
may be under-estimates,14 it is possible that the frequency of depression simply exceeded 
anticipated rates over the 6-month review period and all cases of depression were managed 
appropriately.  Unfortunately, given the paucity of recorded information pertaining to screening, 
assessment and diagnosis of depression for those individuals receiving treatment, it was not 
possible to ascertain whether prescribed treatment was appropriate based on recommended best 
practices for PSD.     
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4.1 Understanding Current Treatment Practices 
It was, however, possible to inform our understanding of current treatment practices by 
examining a variety of factors that might influence the decision to treat PSD in the absence of 
screening, assessment or diagnosis.  These included known risk factors for PSD and selected 
indicators of current practice such as charted clinical observations.  Regression analyses 
demonstrated that the decision to prescribe an antidepressant medication for the treatment of 
depression was influenced by a limited number of variables not associated with the identified 
elements of best practice for PSD. Of these variables, the use of antidepressants at admission 
proved to be the single most important factor influencing treatment.  If there was documented 
pharmacotherapeutic treatment in the patient record at the time of admission, that patient 
continued to receive treatment with antidepressants throughout her/his rehabilitation stay in 
every case. A model for receipt of pharmacological treatment PSD that included this variable 
together with motor function at admission and the presence of notations regarding depression in 
the patient chart accounted for 76% of the variance in the decision to provide treatment.  
However, inclusion of ‘treatment at admission’ resulted in an unstable model.  In a second, post 
hoc model, removal of this variable resulted in the inclusion of previous history of psychiatric 
illness as a significant predictor; however, this new model, without treatment at admission, 
accounted for a substantially smaller proportion of variance.     
While elements of best practice were not identified as significant predictors of which 
individuals received treatment, the variables that were associated with treatment have reasonable 
face validity.  Severity of functional limitations and previous history of depression or other 
psychiatric illness, for instance, are both well-documented risk factors for post-stroke 
depression.99, 100, 105 Informal observations of mood documented in the medical record suggest 
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that, to some unknown extent, observation of mood or mood-related behaviour is part of current 
clinical practice within the participant inpatient rehabilitation programs.  However, charted 
notations that reflect possible clinician awareness of depressive symptomatology and/or the 
prescription of an antidepressant should not be considered an appropriate substitute for formal 
screening and assessment practices in the diagnosis of depression.   
4.1.1 Clinical Observation  
In the present study, there were notations regarding depression or mood recorded in 138 of 
the abstracted patient records (47%). A cursory examination of the content of these notes 
revealed notations that were very brief and most often described the patient as “depressed”, 
“teary” or as displaying “flat affect”.  Informal or ad hoc observations such as flat affect and 
depression, sadness or tearfulness can correspond to symptoms of depression such as apathy and 
lack of motivation or emotional lability noted by staff as important and likely to prompt 
screening.  However, the rate of formal screening was low overall (13.9%), despite the frequency 
with which these important symptoms were recorded.  Given that notations regarding mood were 
identified as a significant predictor of treatment, it is likely that clinical observations were being 
used as a substitute for formal screening and assessment in the identification of post-stroke 
depression rather than as a trigger for the process of identification and assessment associated 
with best practice.  Practitioners relied more often on their skill and experience in clinical 
observation to inform treatment than on the results of formal screening and assessment.   
In the staff survey administered as part of the current audit process, approximately 57% of 
respondents indicated that clinical observation, either alone or in combination with more formal 
processes, was used to assess depression at the time of the study.  Although screening 
questionnaires were considered useful and a means to reduce uncertainty, when asked about the 
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relative usefulness of clinical observation compared to formal screening tools, survey 
respondents indicated that they did not believe formal screening to be more or less helpful than 
clinical observation.  While survey respondents did not rate the recognition of symptoms of 
depression as difficult, it is well-documented within the research literature that physician, nurse, 
or therapist recognition of depression based on clinical observation alone is often inaccurate.106-
113
 
Su et al.113 examined referrals to a psychiatric service made by non-psychiatric physicians 
over a 5-year period in order to determine the accuracy of clinical observations in the 
identification of several psychiatric disorders.  The authors reported that, in the case of 
depression, observations made by referring non-psychiatric physicians were accurate in only 
31.4% of cases referred for additional assessment.  Similarly, the authors of a report describing a 
meta-analysis of 36 studies examining the recognition of depression using clinical observation by 
non-psychiatric physicians reported a summary sensitivity of 36.4%.108 However, in the same 
study, summary specificity was 83.7%, suggesting that non-psychiatric physicians may be more 
adept at recognizing individuals who are not depressed than those who are.  It should be noted 
that, in this analysis, some of the studies identified for inclusion by the authors did not use a 
clinical interview or DSM-based diagnosis as the gold standard against which physician 
performance was assessed.  Several studies used self-report measures, such as the Beck 
Depression Inventory or the Geriatric Depression Scale, instead.   
Mitchell and colleagues109reported the meta-analysis of 41 studies in which physician 
diagnosis based on clinical observation alone was compared to the results of a gold-standard 
diagnostic interview.   Pooled analysis based on data collected from 50,371 patients 
demonstrated that, overall, general practitioners identified depression correctly 47.3% of the 
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time.  In studies that examined both the ability to identify and to rule-out depression, it was 
determined that the sensitivity and specificity of clinical observation was 50.1% and 81.3%, 
respectively.  As in the analysis performed by Cepoiu et al.108, physicians appeared more skilled 
at ruling out depression.  However, Mitchell et al.109 also demonstrated a tendency toward over-
diagnosis of depression such that the number of false positives generated through clinical 
observation may exceed true positives by as much as 3 to 1.  Further, the greatest risk for 
generating false positive diagnoses occurred in populations of individuals with known risk 
factors for depression.   In addition, accuracy of clinical observation can be reduced in cases of 
late life or minor rather than major depression.111, 112  Given that the average age of individuals 
who experience stroke is 70 to 75 years and that there is an elevated risk for depression 
following stroke, there also may be an elevated risk for misdiagnosis of PSD associated with the 
use of clinical observation by non-psychiatric physicians.  The tendency toward over-diagnosis 
in the older, high-risk population of individuals with stroke based on clinical observation could 
have contributed to the elevated rate of treatment found in the present study.   
   Fortunately, the potential for false positives in the identification of depression can be 
managed effectively by a multi-step assessment process, such as the one recommended within 
the Canadian Best Practice Recommendations.109 These recommendations begin with the 
identification of possible cases of depression through formal screening.  This process of 
classification of individuals as possibly depressed or not depressed can be enhanced by the 
addition of standardised screening tools.  Lowe et al.107 conducted a study in order to perform 
direct comparisons between the results of a gold standard, DSM-based clinical interview for the 
diagnosis of depression and a variety of standardised screening tools as well as unassisted non-
psychiatric physician diagnosis.  Clinical observation by a physician was associated with 40% 
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sensitivity and 87% specificity for major depression and 41% sensitivity and 90% specificity for 
any depressive disorder.  However, use of a formal screening tool was associated with a dramatic 
improvement in sensitivity.  For example, the authors reported that the Hospital Anxiety and 
Depression scale was associated with a sensitivity of 81%.  Interestingly, this is the tool that was 
reported most frequently by survey respondents as the one used on their unit for formal 
screening.  It also should be noted that, while the classification sensitivity associated with the use 
of a standardised screening tool is much greater than clinical observation by a non-psychiatric 
physician, the same is not true for specificity.  In fact, Lowe et al.107demonstrated that, relative to 
a gold standard diagnosis for depression, physician assessment specificity was substantially 
higher (90%) than that associated with the HADS tool (75%).   
Of course, it may not always be the attending physician who is responsible for making the 
clinical observations used in the decision to treat PSD.  The physician may be taking into 
consideration both written observations as documented in the chart and uncharted, verbal, 
observations made by other members of the clinical team.  Unfortunately, there is no evidence to 
suggest that the clinical observations made by other healthcare professionals are any more 
accurate than those made by non-psychiatric physicians.  In a review and meta-analysis of 22 
studies, Mitchell and Kakkadasam reported a pooled sensitivity of 43% and a specificity of 
79.6% for the classification of depression based on the clinical observation of nurses working in 
inpatient settings.110  Across all care settings (i.e., primary practice and community, inpatient and 
nursing homes), overall sensitivity and specificity were 42.1% and 83.6%, respectively.  The 
authors proposed that, while nurses typically spend more time with patients and, therefore, might 
be expected to produce more accurate patient classification based on their observations, they are 
more cautious about diagnosis than physicians. 110, 112  
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Rehabilitation therapists also can contribute to clinical observations influencing the 
diagnosis of depression.  However, like physicians, therapists may have a tendency to over-
pathologize.  Ruchinskas106  asked physical and occupational therapists about the presence of 
depression in individuals to whom they had provided services at the time of discharge from a 
geriatric rehabilitation service. When the therapist ratings were compared to the results of the 
Geriatric Depression Scale (GDS), there was no association between therapist experience and the 
identification of possible depression for either the physical therapists (r=-0.12) or the 
occupational therapists (r=-0.05).  One-third of patients were rated as depressed by the 
rehabilitation therapists, but only 17% were identified with possible depression using the (GDS).  
In addition, contrary to what might be expected, increased patient contact was not associated 
with improved accuracy and, in fact, as length of stay increased, the accuracy of therapists’ 
observations decreased. 106     
The clinical significance of the relative accuracy of clinical observation in the diagnosis of 
depression is determined by the actions taken based on accurate and timely observations.  Based 
on the findings from the current study of inpatient rehabilitation programs in Southwestern 
Ontario, clinical observation may be taking the place of screening, assessment and diagnosis of 
depression following a stroke.  Rather than triggering the first step in a multi-step assessment 
process that would lead to an informed and accurate diagnosis followed by treatment, 
pharmacotherapy may be prescribed based on clinical observation alone, in the majority of cases.  
Given the elevated risk of false positive diagnoses within this patient population, this approach 
could contribute to the inflated rate of treatment documented by the present audit.   
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4.1.2  Risks Associated with Over-Treatment    
Treatment and remission of PSD may result in improved physical and cognitive recovery 
as well as reduction in risk for mortality.  However, use of antidepressant agents, even SSRIs, is 
not without risk, particularly for individuals who are not experiencing depression.    Based on 
data reported by 570 general practices in the United Kingdom from 1996 to 2007, Coupland et 
al.114 demonstrated that, in individuals 65 years of age or older, the use of any type of 
antidepressant therapy was associated with an increased risk for mortality, attempted 
suicide/self-harm, falls, fractures and upper GI bleeding.  However, patterns of risk varied with 
the type of antidepressant used.  Use of SSRIs, the most commonly prescribed antidepressant, 
also was associated with increased risk for stroke/transient ischemic attack, myocardial infarction 
(MI), seizures and hyponatraemia.  In the present study, SSRIs accounted for 72% of all 
antidepressants prescribed.   
It should be noted that, although approximately 10% of patient records included in 
Coupland et al.114 were obtained from individuals with previous stroke, there were no analyses 
reported that examined the use of antidepressant agents within this subgroup specifically.  
Instead, analyses of risk were adjusted for the presence of previous stroke as a potentially 
confounding factor.114  In a retrospective study conducted in the United States, Ried et al.115 
examined the impact of SSRI use on mortality risk specifically in individuals with stroke. 
Maximum follow-up time was approximately 7 years.  The authors reported that a diagnosis of 
depression either after the stroke or both before and after the stroke event was associated with a 
significantly increased risk for mortality when compared to no depression.  Use of an SSRI 
antidepressant following stroke was associated with a significant reduction in mortality risk only 
for those individuals receiving treatment both before and after the stroke (HR=0.31 95% CI 0.11, 
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0.86) when compared to no treatment.  Although there may have been some benefit associated 
with treatment after the stroke only for individuals with PSD, this effect did not reach statistical 
significance (HR=0.57; 95% CI 0.25, 1.32).   
Both of these studies were retrospective and based on the abstraction of information from 
either databases or medical records and, therefore, susceptible to bias.  Results should be 
interpreted with some caution.  However, as with any drug, use of antidepressants should be 
considered within the context of possible risks as well as potential benefits.  Treatment in the 
absence of appropriate identification, assessment or diagnosis may place individuals at 
unnecessary risk for any or all of the adverse effects associated with the use of antidepressant 
medications. Although SSRI use following stroke may be associated with a reduction in 
mortality risk, this may apply only to those individuals who also received treatment with an SSRI 
in the 6-month period preceding the stroke event.   
In the present study, a total of 44 individuals were identified as having a recorded history 
of depression on admission to inpatient rehabilitation.  Previous history of depression was 
identified as a significant predictor of treatment, indicating that individuals who had experienced 
depression previously were more likely to receive pharmacotherapy for depression.  Although 
the receipt and timing of treatment for any pre-stroke episodes of depression were not recorded, 
these individuals may be among those most likely to benefit from treatment, at least in terms of 
reduction of risk for mortality.  For the three individuals receiving a formal diagnosis of PSD, it 
is likely that the risks of treatment would be outweighed by the benefits.  However, for many 
patients who received treatment, no formal diagnosis was made and the potential for harm given 
the risks associated with antidepressant use should be considered.     
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4.2 Understanding Adherence to Best Practice Recommendations  
The creation and dissemination of evidence-based recommendations for best practice does 
not guarantee that they are read, understood or implemented in clinical practice.  Many factors 
influence the uptake and implementation of best practice recommendations.  In any attempt to 
understand compliance with recommendations, attention should be paid to variables functioning 
at different levels within the implementation process that include the individual healthcare 
practitioner as well as the program or organisational context.116   
4.2.1 Organisational Factors  
Management support is an important facilitator in the process of implementation.  A 
supportive organisational structure can enhance the effectiveness of implementation 
interventions such as education and training or audit and feedback.117, 118    Lack of support from 
superiors, in addition to insufficient staff and time, have been acknowledged as the most 
commonly-identified barriers to guideline implementation at the level of the organisation.119  
Leadership support and an organisational vision in line with the adoption of best practices, 
provision of staffing and other resources, as well as embedding best practice within 
organisational protocols and documentation systems promote positive staff attitudes and beliefs 
and facilitate adherence.116     
In the present study, post-stroke depression was identified as a priority issue by 
rehabilitation managers at three of the five participating rehabilitation programs.  Prioritisation 
was accompanied by the development and implementation of a formal protocol or strategy for 
the identification and treatment of PSD at two of these three facilities.  When one examines the 
overall frequency with which adherence to the elements of best practice were recorded at each 
participant program, the two facilities with an established strategy, endorsed by program 
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management, had the highest rates of adherence to best practice recommendations in terms of 
screening and assessment.  However, it is not possible to determine whether this was attributable 
to the presence of a management-endorsed protocol.  The facilities that reported having a 
strategy in place for the assessment of depression also were the largest of the participating 
programs and may have had more staff and other resources available to them to facilitate 
adherence.  
Despite prioritisation of PSD, the frequency of screening and assessment within the 
institutions where official strategies were in place was not as high as one might have anticipated. 
Program managers from these facilities reported problems with resource limitations in addition 
to difficulties with the development of standardised documentation systems that would ensure all 
screening efforts were recorded and placed in the chart.  It is possible that documentation issues 
had not been resolved at the time of the audit, and that screening for depression was performed 
more frequently than was recorded.    
4.2.1.1 Revising Professional Roles and Team Processes 
National guidelines, such as the Canadian Best Practice Recommendations for Stroke Care, 
do not provide instructions regarding the development of strategies for implementation at the 
local level.120  Each local facility or program often is faced with the daunting task of developing 
their own protocols in isolation. Practical organisational considerations for developing and 
implementing protocols include identification of managers and staff to function as champions, 
revision of professional roles to improve performance of the targeted behaviours, and staff 
training, in addition to documentation or information management.116, 117, 121  Revising 
professional roles and setting team priorities and expectations can contribute to successful 
implementation of best practice and improve quality of care.117  This process should not be 
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undertaken by leadership alone.  Participation of the rehabilitation team in the process of 
developing implementation strategies, including revisions to professional roles and 
responsibilities, increases agreement with and adherence to best practice recommendations.122     
Team involvement in the process of change leading to collective agreement in how care is 
delivered can result in a higher uptake than when change is directed by an individual leader or by 
a single professional group, particularly where a team approach to care is already the norm,121, 123 
as is the case in the stroke rehabilitation programs identified in the current study.   In responding 
to the survey, rehabilitation managers identified difficulties in changing team behaviour as a 
barrier to implementing strategies for the adoption of best practice recommendations for PSD.  
However, it is unclear to what degree the clinical team at each participating facility has been 
involved in the development of strategies for implementation.  For instance, in one of the two 
facilities with an official protocol, the process of strategy development and implementation 
involved only the rehabilitation manager and a single representative of the professional group 
being given responsibility for the practice of formal screening.  The team should be given the 
opportunity to discuss the recommendations within the context of its own program and to 
evaluate which changes should be undertaken to support best practice.123  This approach has the 
potential to prevent functions such as formal screening for depression from becoming “just 
another piece of paper to keep track of and complete” (response from rehabilitation management 
survey).   
Within the team environment, identification of a staff champion or champions who take 
primary responsibility for implementing and sustaining best practice can help to facilitate 
change.116  Screening or identification of depression might fall reasonably within the roles of 
social workers, for instance, since psychosocial aspects of stroke rehabilitation already are 
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considered to reside within their professional domain.124  In the staff survey, respondents 
indicated most often that social workers and nurses were responsible for screening.  This is not 
surprising given that, at one of the large institutions with an official protocol in place, social 
workers had been assigned responsibility for screening, while nurses had been given that 
responsibility at the other facility.    
4.2.1.2 Resource Limitations  
It is acknowledged that including mental healthcare professionals on rehabilitation teams is 
associated with increased accuracy of diagnosis of depression.106, 113 However, in the context of 
inpatient stroke rehabilitation, mental healthcare professionals are an under-resourced profession.  
In the present audit, four of five participant programs reported that a lack of resources and poor 
or no access to psychiatrists or psychologists are important barriers to implementation of best 
practice recommendations for post-stroke depression. This finding was substantiated by a 
marked reduction or elimination of recorded adherence to recommendations pertaining to referral 
for formal assessment and diagnosis of depression by a qualified mental healthcare professional 
at most facilities.   
In an audit of stroke services in the UK, Bowen et al.91 discovered that only 28% of 
specialised stroke units, representing 75% of all stroke units in that country, had some, though 
often limited, access to clinical psychology or psychiatry services.  The authors suggested that, 
while the addition of mental healthcare professionals to the stroke unit team is valuable, it may 
be cost-prohibitive given the relatively high rates of reimbursement required to access these 
services.  Even when the psychiatrist or psychologist is viewed as an occasional consultant to the 
program rather than hired as a team member, the fees for service associated with consultation 
may exceed the amounts designated for this use within current departmental budgets. Without 
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access to a qualified mental healthcare professional, team members must rely upon a non-
psychiatric physician’s ability to recognise and diagnose depression.113  Indeed, this may be the 
situation within the rehabilitation programs participating in the current study.  In the absence of 
access to mental healthcare resources, practitioners may rely on clinical observation to guide 
treatment decisions, as noted earlier.   
It may be possible to find solution to the problem of formal assessment and diagnoses 
within the climate of limited resources for mental healthcare reported by rehabilitation managers.  
Examination of the guidelines within the local context of care might reveal potential adaptations 
that could facilitate assessment and diagnosis without compromising the integrity of the original, 
evidence-based recommendations.120   For instance, it is suggested that social workers could play 
a key role in the assessment and diagnosis of depression given that depression is already within 
their professional domain.124  Other rehabilitation team members expect their involvement in this 
area and they are skilled in active listening, observations of behaviour, reflection and exploration 
through open-ended questioning, all of which are skills required to conduct a standardised 
interview.  There are tools, such as the Mini International Neuropsychiatric Interview (MINI), 
which can be used to improve the process of identifying cases of depression accurately.124  
Although social workers cannot provide a formal diagnosis, they can provide non-psychiatric 
physicians with the results of an interview-based assessment such as the MINI, in order to 
facilitate a more informed, thorough and sensitive assessment and diagnosis by attending 
physicians.  Of course, any such adaptation should be developed using a team approach in which 
possible role revisions and changes to processes of care are examined and agreed upon 
collectively.116, 121  In addition, adaptations that include interview-based assessments other than 
the recommended gold standard clinical interview and diagnosis by a qualified professional 
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should be validated.  Of course, in the present study, managers reported a lack of resources in 
terms of access to psychiatrists or psychologists.  It is also possible that the staffing complement 
of social workers would not be sufficient to assume increased responsibilities associated with the 
administration of clinical interviews and provision of recommendations for diagnosis and 
treatment of PSD.   
4.2.2 Clinician-Level Factors   
To understand adherence to best practice recommendations for screening, assessing and 
diagnosing post-stroke depression, it is important to explore characteristics of the rehabilitation 
team members as well as organisational conditions which facilitate or impede implementation.117  
Common factors associated with adherence to recommendations at the level of the healthcare 
practitioner include awareness of the existence of the recommendations or guidelines, familiarity 
and agreement with the content of the guideline.119  Although access may be provided, education 
and training are important to promote both awareness and familiarity with the guideline content 
and with the skills and abilities necessary to apply the recommendations correctly.125, 126    
In the present study, access to the guidelines did not appear to be a concern.  
Approximately three-quarters of respondents indicated that they had access to the guidelines.  
However, in spite of having access, only 30% of individuals with access were aware of the 
specific recommendations made regarding the identification, assessment and treatment of PSD.  
In addition, respondents provided only neutral ratings overall with regard to their training, skills, 
and comfort in performing screening for PSD.  Provision of additional information and 
educational opportunities regarding the best practice recommendations and the skills required for 
clinical implementation could improve both awareness and adherence.125, 126  Indeed, 
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rehabilitation managers suggested that additional training and educational resources for staff 
would be beneficial to the process of implementation of best practice recommendations.   
Clinician age and experience also may have played a role in the level of adherence found 
in the present study.  It has been reported previously that younger or less experienced healthcare 
professionals are more likely to use guideline recommendations in their practice than their older 
or more experienced counterparts.119  Belief in one’s own competence as well as the inertia of 
previous practice, which may increase with experience, also can be a barrier to the adoption of 
best practice.126  In the present study, 83% of survey respondents reported having more than 10 
years of experience within their reported profession.  Respondents may have been mostly 
experienced and confident clinicians, comfortable with their current skills and practices, and less 
likely to adopt best practice recommendations.   
 4.2.2.1 Behavioural Intent and the Adoption of Best Practices 
The theory of planned behaviour comes from the field of social psychology and is based on 
the principle that there is a positive association between intention and overt behaviour.127-129  
Behavioural intent is composed of attitude (beliefs about the behaviour), subjective norms 
(expectation and motivation to perform the behaviour) and perceived control.  Perceived control 
over the behaviour is influenced by several factors including the knowledge and skills of the 
individual, time and opportunities to complete the behaviour, and perceived autonomy in 
decision-making about the behaviour.  Theoretically, the more positive the beliefs and the 
subjective norms, and the greater the perceived control over the behaviour, the stronger the intent 
will be and the more likely it becomes that the individual will perform the behaviour.129, 130     
The theory of planned behaviour has been used frequently in studies of health-related 
behaviour.  Godin et al.131 performed a systematic review and analysis of the use of this theory in 
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examining intention and behaviour in healthcare professionals.  Based on data reported in 78 
studies, application of the theory of planned behaviour could account for 59% of the variance in 
behavioural intention and 31% of the variance in observable behaviour.  The authors suggested 
that the theory of planned behaviour provides a valid model for the study and prediction of the 
behaviour of healthcare professionals within defined contexts of performance.131  In fact, the 
questions and content of the staff survey used in the present study are based on the theory of 
planned behaviour.92  In its original application, the survey was used to examine differences in 
attitudes, norms and perceived control in groups of behavioural intenders and non-intenders, 
classified on the basis of a response to a single survey item in an attempt to predict adherence to 
guidelines.  However, this type of classification and analysis were beyond the scope of the 
current study.  Rather than attempting to predict behaviour, the current project gathered 
information to inform a retrospective examination of documented behaviour within a specific 
clinical context.   
Nash et al.129 examined adherence to established guidelines regarding the assessment of 
pain and discovered that nurses who believed in the importance of assessment and felt that it was 
expected of them were more likely to carry out the required assessment.  In the present study, 
survey items addressing beliefs about the identification and management of PSD received the 
strongest, most positive endorsements overall.   Staff indicated that screening is an important and 
useful task and that depression can be easily and effectively treated once diagnosed.   
Unfortunately, belief in the importance of identification and management of PSD did not appear 
to be associated with higher levels of documented compliance with best practice 
recommendations.  In addition, while respondents generally viewed screening as part of their 
professional roles, perceptions regarding specific expectations associated with screening 
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behaviour were less clear.  In part, this may be attributed to the fact that, for respondents from 
the two largest participating programs, responsibility for screening had already been assigned to 
designated individuals within specific professional groups, thereby shifting expectations for task 
completion away from many respondents.         
Identification of barriers to adoption of best practice is particularly important, given the 
juxtaposition of positive attitudes and beliefs about identification of PSD with the lack of 
documented formal screening.  However, item responses with respect to perceived control were 
often ambiguous.  Mean (and median) scores for most items representing anticipated barriers 
were neutral with only some respondents rating items as obstacles.  The only item that emerged 
clearly as a potential barrier reflected perceived autonomy in decision-making.  Respondents did 
not feel that it was their decision to either screen or ask for an individual with stroke to be 
screened.  Overall, in terms of behavioural intent, there was no distinctly negative result in terms 
of attitude, beliefs, or expectations that would prevent the implementation of best practice 
recommendations for post-stroke depression.  Instead, the positive result in terms of attitude and 
belief suggests that clinical staff may be more inclined to participate in a strategy for adoption of 
best practices, particularly should they be provided with greater autonomy within the process of 
implementation, as was discussed earlier.   
  4.2.2.2  Perceived Barriers to Adherence 
Agreement with the content of guidelines or recommendations is an important factor in 
compliance.119, 120, 125  Although explicit agreement with the recommendations was not solicited 
by any of the items in the staff survey used in the current project, respondent attitudes and beliefs 
regarding screening for PSD were favourable, in general.  However, clinicians did not provide a 
clear endorsement of formal screening over clinical observation, which appears to be 
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representative of current practice.  As mentioned previously, continued reliance on clinical 
observation to identify and to diagnose depression may be explained, in part, by a lack of 
resources and poor access to mental healthcare services or by duration of experience and practice 
inertia. It also could also be that clinical staff considers the implementation of formal screening 
as unnecessarily rigid when compared to the current practice of clinical observation.  Perception 
of a recommendation as too artificial or rigid within the local context has been identified as a 
barrier to implementation.120  
Other commonly identified barriers with respect to the implementation of best practice 
recommendations include objections by health care professionals that the guidelines are 
inappropriate to patients, the perception that compliance would not be in accord with patient 
preferences, and the lack of time or opportunity to comply with the guidelines.120, 125 The 
appropriateness of using screening questionnaires to assess individuals with stroke received a 
neutral rating as did statements addressing the impact of cognitive and communication 
impairments on screening.  Although the mean and median scores for items assessing patient 
perceptions regarding depression were generally neutral, it is clear that some respondents feel 
that patients regard depression in a negative light and would be upset by a discussion of 
depression.  Lack of time was not identified as a barrier to screening in the present study.    
4.3  Parkwood Hospital Pilot Study 
A pilot audit of charts for patients admitted for inpatient stroke rehabilitation over a period 
of 6 months (May to October 2009) was completed at Parkwood Hospital in 2010.  The purpose 
of that audit was to examine best practice recommendations for depression, and to test the audit 
tool, the staff survey and the NRS data reporting processes.  Following completion of the initial 
chart audit, interactive information and education sessions were held to review the best practice 
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recommendations and to present the pilot audit results.  Subsequently, implementation of the best 
practice recommendations for PSD was endorsed by the hospital Stroke Council.  The 
responsibility for identification of PSD was assigned to the departmental social workers and a 
protocol for formal screening was created by rehabilitation management together with the lead 
social worker and implemented on the unit.  With the repeat audit complete, the pilot audit at 
Parkwood Hospital may be viewed as a very basic audit and feedback intervention.   
In the 2009 audit, formal screening for depression was recorded in 4.9% of identified 
patient records (n=123).  This rate, which pre-dates the development of an official strategy for 
the adoption of best practices for PSD at Parkwood Hospital, is much closer to the rates recorded 
in smaller, non-protocol facilities participating in the current audit.  This suggests that the initial 
audit and the subsequent development of a protocol did have a positive impact on the 
implementation of the best practice recommendation for formal screening.  This effect was, like 
the initial Parkwood protocol, limited to formal screening for the possible presence of PSD.    
The frequency of referral for formal assessment decreased from 9.8% to 7.6%, since the pilot 
study was completed.  In spite of the decline in assessment, treatment rates increased from 32.5% 
to 39.8%.  Of the 47 patients in the present study who were treated for depression at Parkwood, 
only 3 had been screened, assessed and diagnosed with PSD according to best practice 
recommendations.   
It seems reasonable to anticipate that if healthcare practitioners receive constructive 
feedback that their current clinical practices are not in keeping with accepted best practice 
recommendations, they would be motivated to change their practice patterns.  However, the 
modest increase in rates of formal screening demonstrated at Parkwood Hospital as part of the 
current study are in keeping with a recent Cochrane review in which the authors suggested that 
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audit and feedback strategies are effective but result in only small to moderate improvements in 
practice. 132   
A team-based approach to implementing best practice guidelines which encourages 
participation in information exchange, including the development of feedback that is tied to 
reasonable and specific goals, can improve adherence to best practices, particularly within a 
context in which a team-based approach to care is already the norm.93, 122  Rather than limit 
participation in the process of developing a strategy for the adoption of best practices for post-
stroke depression to the rehabilitation manager and a single social worker, more team members 
whose practice may be affected by the implementation of these best practice recommendations 
should be invited to become engaged in the process.  At the time of the second chart audit, there 
continued to be difficulty in creating clear expectations around documentation and, although 
discussed, there was no mechanism created for the provision of frequent, goal-based feedback.  
Provision of more frequent, meaningful feedback tied to specific goals may help to establish 
accountability, increase knowledge of best practices and improve adherence.122   
4.4  Limitations of the Present Study 
4.4.1 Proxy Assessment of Clinical Practice   
The quality of clinical practice often is assessed indirectly using a proxy measure rather 
than via direct observation of clinician behaviour.  Abstraction of data from patient records, or 
retrospective chart review, is currently the most common form of proxy assessment used in 
quality assurance studies.133, 134  While this is the simplest and best understood measure, the chart 
may not be an accurate or reliable representation of all processes of care.133  Results of studies 
using this form of proxy assessment may be subject to recording bias.  Busy practitioners may do 
more than they record and the chart may not reflect all of the clinical events occurring over the 
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course of an inpatient stay accurately.133  The accepted gold standard for the evaluation of 
clinical practice is the direct assessment of standardised patients.133, 134  However, this approach 
is difficult logistically, time-consuming and prohibitively expensive, particularly for large, 
regional studies.133  In addition, direct assessment may promote changes in practice in order to 
comply with perceptions of what clinicians should be doing.134   
Although incomplete recording practices can result in underestimation of the frequencies 
of some clinical behaviour, some types of behaviour are more susceptible to underestimation 
than are others.  Data pertaining to physical examinations, blood pressure, lab test orders and 
results, prescription of medications and referrals for specialist assessment are recorded more 
reliably and less ambiguously than are activities related to counselling or prevention 
interventions.133, 134  In the present study, the elements of best practice for PSD were represented 
by formal screening, referral for specialist assessment and prescription of medication(s).  The 
latter two elements (referral for specialist assessment and prescription of medications) are among 
the types of information most likely to be recorded accurately within the patient record.  
However, elements such as formal screening for depression, patient history of mental illness or 
previous stroke, and clinical notes regarding depression may have been affected by recording 
bias.    
Other identified problems associated with retrospective chart reviews include illegibility, 
missing reports and variability in the skill and experience of the individuals completing the chart 
abstractions.133  Although some investigators and clinicians might assume that eventually the 
electronic patient record will improve the quality of the health record, changing the medium does 
not guarantee that the information stored will be more accurate, more complete or more useful.133  
In the present study, illegibility remained a problem despite an increase in electronic information 
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management.  Paper charts are still used to some extent in most centres and the majority of 
information is still handwritten.  Even in centres with electronic patient records, these most often 
consist of scanned copies of the mostly hand-written paper chart created for the inpatient stay.  In 
the present study, abstractions were conducted by an experienced researcher trained in chart 
abstraction in an effort to minimise bias.    
4.4.2  Response Biases  
Data collected using the online survey could have been subjected to a number of different 
forms of response biases.  Due to the requirements for anonymity for survey respondents, 
responses could not be differentiated by participant rehabilitation program.  Therefore, between-
program differences in responses or response patterns could not be examined.    
4.4.2.1 Non-Response Bias 
In general, non-response bias becomes a concern when there is less than a 50% response 
rate.135  In those instances, there is a greater chance that there is something inherently different 
about those individuals who chose to respond versus those who did not.  Responders are more 
likely to be a self-selected group distinguishable from non-responders or from those who refused 
to participate.135   The response rate for the staff survey used in the present study was 38%.  It 
was not possible to evaluate differences between responders and non-responders because there 
were few data available relative to the potential pool of survey respondents.  All rehabilitation 
managers (100%) provided responses to the management survey.   
In the case of examining adherence to guidelines, a low response rate could be associated 
with lack of access to or familiarity with the guidelines as well as limited agreement with the 
guidelines.125  Non-responders may not consider PSD to be an important issue and are unfamiliar 
or disagree with the current evidence-based recommendations for PSD. Responders, on the other 
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hand, may represent a self-selected group of clinicians who place more importance on PSD, and 
who are more familiar or in agreement with the recommendations than non-responders.   
Other obstacles to participation in surveys include lack of time, lack of encouragement to 
participate in research activities or a perceived lack of opportunity to participate.125  To address 
these types of obstacles to participation, the survey used in the present study was short, required 
approximately 10 minutes to complete, and was easily accessible through available on-site or 
personal home computers with access to the internet.  Invitations to participate were followed by 
written, email reminders and each site was presented with the opportunity for pen-and-paper 
administration of the survey.     
Admittedly, non-response bias is a concern and interpretation of the survey results should 
be approached with the appropriate caution.  However, low response rate, on its own, may be a 
poor predictor of bias associated with non-response.136  In a recent study, Ziegenfuss et al.137 
examined response bias in a group of physicians who were asked to complete a survey 
examining care processes and systems for individuals with diabetes.  Despite a response rate of 
36%, the authors were unable to demonstrate response bias based on the comparison of 
responders with non-responders using summary patient and clinician characteristics.  The authors 
suggested that the greater concern with low response rates may be the attenuation of statistical 
power due to reductions in sample size.137  
4.4.2.2 Social Desirability Responding  
Social desirability responding refers to the tendency of respondents to give what they 
perceive to be socially desirable answers.  When the individual seeks to put her/his best foot 
forward in order to create a positive impression, it may be referred to as “faking good” or 
“impression management”.138(p110)  Topics that reflect good citizenship in some way, such as 
Best Practices for Post Stroke Depression       74 
 
 
 
being well-informed or fulfilling one’s responsibilities, are particularly prone to this type of 
responding.  Questionnaires that address these issues may suffer from over-reporting or inflated 
estimates of compliance with behavioural standards from which respondents gain nothing other 
than an exaggerated appearance of compliance.138  The process of guideline dissemination may 
expose healthcare practitioners to socially-based pressures for compliance that, in turn, promote 
provision of socially desirable responses that are not an accurate reflection of current clinical 
practice.139  This may be especially true when clinicians are aware of guidelines and know they 
should be implemented, but do not change their practice given the presence of barriers such as 
lack of resources, time pressures or deficits in specific training or skills.139   
In a review of studies evaluating adherence to guidelines, Adams and colleagues139 
discovered that self-reported rates of adherence exceeded objectively-determined rates by a mean 
absolute difference of 27%.  Of the 37 self-report measures identified, 87% were associated with 
over-estimates of adherence.  In the present study, the examination of adherence to best practice 
guidelines was not based on the self-report of clinical practice contained in the online survey.  
However, survey responses provided elevated estimates when compared to objective data for 
numbers of patients screened, the implementation of routine formal screening and the proportion 
of patients screening with a formal screening tool.   
4.4.2.3 Central Tendency Bias 
Continuous scale item response formats, such as the Likert scale, may be susceptible to 
central tendency bias, or the reluctance of respondents to endorse extreme categories of the 
scale.138   In general, respondents find it difficult to make judgements without provision for 
extenuating circumstances.  In the present study, respondents may have been influenced to some 
degree by this tendency.  In the section of the survey addressing attitudes and opinions, median 
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scores for seven items were neutral with IQR values (where IQR=Q3-Q1) that indicated 50% of 
responses occurred within a 2 or 3 point range of the neutral value.  However, the response set 
for survey items included strong rather than absolute statements as anchor points to the 7-point 
Likert scale, which may have improved the probability that all categories were used 
appropriately.138   
Chapter 5 
5. Conclusion 
Efforts to promote the adoption of best practice recommendations are best preceded by an 
effort to understand current clinical practice.95, 121  Understanding and achieving change in 
practice occurs on multiple levels including the individual healthcare practitioner, the clinical 
care team and the program or organisation.121  In the current study, a practice audit of adherence 
to Canadian Best Practice Recommendations for Post-Stroke Depression was performed using 
retrospective patient record review at five inpatient rehabilitation programs in Southwestern 
Ontario.  Objective results were supplemented by clinician and rehabilitation management 
surveys.   
Overall, documented compliance with the best practice recommendations for screening, 
assessment and management of PSD was poor. Approximately 14% (41/294) of patients were 
screened formally and very few of those individuals were referred for treatment and diagnosed 
with depression before receiving treatment.  In spite of the lack of formal assessment and 
diagnoses, almost 40% of all patients received treatment with an antidepressant medication for 
depression.  Only three patients who were treated with an antidepressant had been screened, 
formally assessed by a psychiatrist or psychologist and diagnosed with depression.  Overall, 
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individuals who were treated for depression at the time of admission, with more severe 
functional deficits, a history of psychiatric illness and for whom there were documented 
observations about depression were more likely to receive treatment for depression, even in the 
absence of formal screening, assessment or diagnosis.   
The development of protocols or strategies and systems of documentation to support best 
practice promotes adoption.  Two of the participant programs reported developing official 
strategies for the implementation of best practice recommendations for PSD.  While the 
existence of an official strategy appeared to be associated with a modest increase in rate of 
formal screening, it did not improve the progress of patients identified with possible depression 
through the 3 stages of best practice from screening to assessment to treatment.  Referral for 
assessment was not dependent on the results of formal screening in most cases.   
Management from both programs that had developed a protocol for the identification of 
PSD reported difficulty creating clear expectations around a standardised system of 
documentation.   In fact, in all participating programs, the audit process was made more difficult 
by the current systems of documentation employed by each facility.  Documentation of 
screening, assessment or observation of depression or mood in the current study data was 
unsystematic and often difficult to find, despite the acknowledged importance of PSD.  Ideally, 
the development of standardised documentation would include a mechanism for the provision of 
frequent feedback linked to reasonable goals agreed upon by team members.   
Perhaps one of the greatest challenges experienced by rehabilitation programs is the lack of 
resources with which to access mental healthcare services.  Of the 5 participant programs, staff 
in only one had access to a psychiatrist or psychologist who could be consulted in the event of a 
positive result on a formal screening test.  One additional program reported limited access but no 
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funding to support the use of consultation services.  Although patients benefit when there is a 
psychiatrist or a psychologist on the rehabilitation team, the cost associated with their 
involvement may not be available within existing budgets.   
This project represents the beginning attempt to promote the implementation of best 
practices for the screening, assessment and treatment of post-stroke depression.  Facilitation of 
adherence to evidence-based recommendations is a complex process that may depend on a 
variety of program or organisation-level as well as clinician-level factors, such as practitioner 
knowledge and skill as well as familiarity and agreement with the specific elements or actions 
required by the recommendations.  Findings from this study should not be viewed within the 
context of a single audit and feedback intervention.  This project is part of an ongoing effort to 
examine adoption of best practice recommendations for depression across the province.  Results 
from this project will be disseminated to all participating facilities and will be made available to 
interested parties through the Ontario Stroke Network.  It is hoped that, in the future, results of 
the current practice audit will be used to inform the development of a multi-component strategy 
to facilitate adherence to guidelines that relies on a participatory team-based approach, including 
strong administration involvement, especially related to documentation and resource allocation.  
Given that clinician respondents expressed attitudes representative of a climate of positive intent, 
rehabilitation teams may be willing to engage in a process of building and tailoring strategies to 
support implementation of best practice recommendations within their local context.  Clearly, the 
problem of lack of funding for mental health services and limited or no access to these services 
must be addressed by administration, policy makers and/or funders if best practices for the 
identification and treatment of depression are to be implemented in their entirety.  In the 
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meantime, the use of alternative assessment methods in keeping with the integrity of the 
evidence-base should be explored.    
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Appendix 1. Data Abstraction Form 
Pt. ID 
code 
Stroke 
(type,  
location) 
Pre-
admission 
Psychiatric 
diagnosis 
Dep1 
screen 
(Y/N) 
Tool 
used 
Score 
Notes re: possible 
dep. 
Ref for 
dep  
Ax 
(Y/N) 
Tx for dep Notes 
     
 
  
A2: 
 
D: 
     
 
  
A: 
 
D: 
     
 
  
A: 
 
D: 
     
 
  
A: 
 
D: 
     
 
  
A: 
 
D: 
*Dep = depression; A=admission, D=discharge
91 
 
 
 
Appendix 2. Staff Survey  
 
STAFF QUESTIONNAIRE ABOUT 
SCREENING FOR POST STROKE DEPRESSION 
 
For this survey, screening refers to the use of a questionnaire to assess depression 
in patients that you see.  If you do not carry out screening for depression 
personally, please still complete the questionnaire as your responses are equally 
valuable.   
 
For each question please tick (or circle) your chosen response.  All the information 
you provide is completely anonymous.  Thank you. 
 
 
1. What is your profession? 
 Nursing     Physician - Attending Primary Care                         
 Physiotherapist    Physiatrist (physician) 
 Social Worker    Psychiatrist  
 Psychologist     Neurologist    
 SLP      Occupational Therapist    
 Other (please specify) …………………………….. 
 
2. For how many years have you been in practice? 
 Less than 5 years  
 5 – 10 years   
 10 – 20 years  
 More than 20 years 
 
3. Are you employed on a Full-time or Part-time basis? 
 Full-time        
 Part-time 
  
 
PERSONAL INFORMATION 
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ABOUT THE CANADIAN BEST PRACTICE 
RECOMMENDATIONS FOR STROKE CARE 
 
1. Do you have access to a copy of the Canadian Best Practice 
Recommendations for Stroke Care? 
 Yes   
 No        
 I don’t know 
 
2. What form, if any, of the Canadian Best Practice Recommendations for 
Stroke Care have you read regarding the assessment of depression?  
  I have read the full version  
  I have read the summary/concise version  
  I have not read the recommendations 
 
3. Are you aware of the Canadian Best Practice Recommendations regarding 
the assessment of post-stroke depression? 
 Yes   
 No     
 Somewhat 
 
INFORMATION ABOUT YOUR REHABILITATION UNIT 
 
1. Does your unit have access to a clinical psychologist or psychiatrist? 
 Yes   
 No     
 I don’t know 
 
2. Is screening for depression part of your teams’ routine assessment?  
 Yes     Yes, but not all patients are screened  
 No         (only when it is considered necessary)  
 I don’t know 
 
3. How is depression assessed in your unit (check all that apply)? 
 Clinical observation    
 Clinical interview     
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 Depression questionnaires  
 Other (please elaborate)…………………………………………….. 
 
 I don’t know 
 
4. When depression is suspected, in what percentage of cases is a formal screening 
tool used (Check the answer). 
0-20% 21-40% 41-60 61-80 80-100 
     
 
5. What screening tools are routinely used in your unit for assessing 
depression? 
 HADS      (Hospital Anxiety and Depression Scale) 
 GDS        (Geriatric Depression Scale) 
 BDI          (Beck Depression Inventory)                
 VAMS      (Visual Analogue Mood Scales) 
 SADQ      (Stroke Aphasia Depression Questionnaire)                 
 Others (please specify) …………….……………………………… 
 
 I don’t know 
 
6. Which professional disciplines do the screening on your unit (check all 
that apply)? 
 Nursing     Doctor                         
 Physiotherapist    Physiatrist     
 Psychologist     Neurologist   
 Social Worker    Psychiatrist  
 SLP      Occupational Therapist    
 Other (please specify) …………………………… 
 
7. Please estimate the number of patients you have screened for depression 
(or requested that someone else screens for depression) in the last 
month.  
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YOUR VIEWS ABOUT SCREENING FOR DEPRESSION 
 
Please provide answers based on your own personal opinion. 
 
1. Screening patients for depression after their stroke is important. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
2. My professional colleagues think I should screen patients for depression 
after their stroke (or ask for them to be screened). 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
3. Screening patients for depression (or asking for them to be screened) after their 
stroke is expected of me. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
4. I feel comfortable screening patients for depression. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
5. I have adequate skills and training to screen patients for depression (or 
to know when to ask for screening). 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
6. Whether or not I screen patients (or ask for them to be screened) for 
depression is my decision. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
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7. Screening for depression (or asking for someone to be screened) is not 
part of my role. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
  
8. Most screening questionnaires are unsuitable for use with stroke 
patients (e.g. those with communication difficulties, cognitive 
impairment etc). 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
9. Time pressures make it less likely that I screen patients (or ask for 
someone to be screened) for depression. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
10. Screening patients for depression can reduce uncertainty about whether 
or not they have depression. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
11. Screening questionnaires for assessing depression are clinically useful. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
12. Screening for depression is more effectively achieved by clinical 
observation (rather than using screening questionnaires). 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
13. Understanding that a patient is depressed by screening helps me to 
engage them in rehabilitation. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
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14. Recognising symptoms of post stroke depression is difficult. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
15. It is difficult to treat post stroke depression once a diagnosis is made. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
16. Discussing depression treatment options with patients is difficult and 
may cause them to become upset.  
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
17. Most patients feel that a diagnosis of depression is an indication of 
personal weakness. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
18. Antidepressant medications do not work in post-stroke depression. 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
19. Does the presence of communication issues prevent you from 
screening an individual for depression? 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
 
 
20. Does the presence of cognitive issues prevent you from screening an 
individual for depression? 
Strongly  Disagree                                                                       Strongly Agree                      
1 2 3 4 5 6 7 
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ABOUT POST STROKE DEPRESSION 
 
The following are all symptoms of post-stroke depression. Considering 
each one in turn, please indicate to what extent it would influence your 
decision to screen for depression (or ask for screening to be carried out). 
 
Symptoms present 
 
Very likely to                               Very unlikely     
make me consider                         to make me               
screening                           consider screening                                          
Emotional lability 1 2 3 4 5 
Apathy 1 2 3 4 5 
Tension   1 2 3 4 5 
Poor concentration                    1 2 3 4 5 
Reports of feeling guilty 1 2 3 4 5 
Hopelessness 1 2 3 4 5 
Agitation      1 2 3 4 5 
Early waking/insomnia 1 2 3 4 5 
Thoughts of death 1 2 3 4 5 
Suicidal thoughts      1 2 3 4 5 
Lack of motivation   1 2 3 4 5 
Sleepiness 1 2 3 4 5 
Reports of feeling worthless    1 2 3 4 5 
Loss of energy 1 2 3 4 5 
Loss of interest 1 2 3 4 5 
Weight gain or loss                     1 2 3 4 5 
Distractibility 1 2 3 4 5 
 
 
Thank you for taking the time to complete the questionnaire.  Your support 
and involvement in this research is greatly appreciated. 
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Appendix 3. Letters of Consent, Information and Debriefing. 
 
1) Invitation to Participate and Informed Consent 
 
Subject Line: Staff Questionnaire, Screening for Post-Stroke Depression  
 
You are being invited to participate in a research study because you are a healthcare professional 
working in an inpatient rehabilitation setting.  The purpose of this study is to investigate current 
practices regarding the screening and assessment of post-stroke depression in Ontario inpatient 
rehabilitation units.  Participation in this study involves the completion of an online survey that 
asks questions relating to depression screening.  This survey should take approximately 10 
minutes to complete. 
 
There are no known physical or psychological risks associated with this study.  Your 
participation in the study is voluntary and you are free to withdraw at any time or refuse to 
answer any questions without penalty.  Your responses will be entirely anonymous, kept strictly 
confidential, and will not be shared with any other staff members.  No personal identifiers are 
collected or retained.  Information collected will only be used for research purposes.  Please note 
that completion of the survey confirms informed consent to participate.     
 
The dead-line for completing the survey is dateline date.  After this date, the survey will no 
longer be available. The survey is available at:  http://www.surveymonkey.com/s/G9KYLVK 
(to access the survey simply click on the link above or cut and paste the link into your browser’s 
address bar) 
 
Please feel free to ask questions at any time.  If you have any further questions or concerns you 
may contact XXXXXXXXXXXX.   Once you have completed the survey you will receive a 
debriefing form that more clearly describes the purposes and hypotheses of this study.   
 
If you have any questions about your rights as a research participant or the conduct of the study 
you may contact The Office of Research Ethics XXXXXXXXXXX. 
 
If you have additional questions regarding the study in general, you may also contact the 
principal investigator, XXXXXXXXXXXXXX.   
 
Thank you in advance for your time and consideration,  
 
  
99 
 
 
 
2) Reminder Invitation    
 
Subject Line: Staff Questionnaire, Screening for Post-Stroke Depression : Survey reminder.   
 
Last week an invitation was sent to you requesting your completion of a survey gathering 
information regarding screening for post-stroke depression.  If you have already completed the 
survey, thank you.  If you have not, I invite you to complete this survey.  
 
The survey is available at:  http://www.surveymonkey.com/s/G9KYLVK 
(to access the survey simply click on the link above or cut and paste the link into your browsers 
address bar) 
 
This survey should take about 10 minutes to complete.  The dead-line for completing the 
survey is (deadline date).  After this date, the survey will no longer be available.  
 
Your completion of this survey is completely voluntary. If you have decided not to participate in 
this study, simply delete this e-mail message. You are free to withdraw at any time or refuse to 
answer any questions without penalty.  Your responses will be entirely anonymous, kept strictly 
confidential, and will not be shared with any other staff members.  No personal identifiers are 
collected or retained.   
 
Please feel free to ask questions at any time.  If you have any further questions or concerns you 
may contact XXXXXXXXXX. Once you have completed the survey you will receive a 
debriefing form that more clearly describes the purposes and hypotheses of this study. 
 
 If you have any questions about your rights as a research participant or the conduct of the study 
you may contact The Office of Research Ethics at XXXXXXXX. 
 
If you have additional questions regarding the study in general, you may also contact the 
principal investigator, XXXXXXXXXXXXXXX. 
 
Thank you in advance for your time and consideration. 
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3)    Debriefing Letter 
 
Subject Line: Staff Questionnaire, Screening for Post-Stroke Depression – Study Information 
(debriefing) 
 
Adherence to Canadian Best Practice Recommendations for Stroke Care: Assessment of 
Post-Stroke Depression 
   
The Canadian best practice recommendations for stroke care were published in 2008 and updated 
in 2010 (Lindsay et al. 2008, 2010).  This document was developed to coordinate Canada’s 
approach to stroke prevention, treatment, rehabilitation, and community reintegration by 
enhancing access to high-quality and efficient stroke services for all Canadians across the 
country.  The primary goal of these recommendations is to improve patient care by applying 
best-practice evidence. 
 
 Several best practice recommendations are made regarding the assessment and management of 
post-stroke depression during inpatient rehabilitation.  For example, it is recommended that all 
patients in stroke rehabilitation should be screened for depression and that patients identified as 
being at risk during screening should be referred for further assessment.  However, it is currently 
not known what proportion of stroke rehabilitation patients are screened for depression nor is it 
know what proportion of patients are referred for additional assessment. 
 
The objective of this study is to assess the extent to which rehabilitation in Ontario have adopted 
the Canadian best practice recommendations pertaining to the identification, assessment and 
management of post-stroke depression.  The survey you have just completed will be used to 
supplement and give context to information gathered through retrospective methods. 
 
It is hypothesized that a relatively large percentage of patients are not screened for the presence 
of depression and that many individuals identified as being at risk are not referred for further 
assessment.  Because adherence to the Canadian best practice recommendations should enhance 
the quality and efficiency of stroke rehabilitation, it is of great importance that we determine if 
these recommendations are being implemented.  Identification of our shortcomings in meeting 
these goals is the first step towards ensuring that patients in Ontario receive the best stroke care 
possible.  In the next step of the process, we hope to use the information gained in the present 
study to inform a process of knowledge implementation that will include addressing identified 
barriers, finding ways to improve the local relevance of existing guidelines and developing 
clinically applicable implementation strategies.  It is hoped that, through this process, we will 
promote improvements in the recognition and treatment of post stroke depression which may 
result in improved physical and cognitive recovery for individuals who have experienced stroke.   
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Appendix 4. Rehabilitation Management Survey  
 
 
 
 
 
 
1. Does your facility have an official protocol or strategy for identification and management of 
post-stroke depression?      Y          N 
 
a. If yes, proceed to Part A 
b. If no, proceed to Part B 
 
Part A  
 
1. Are you familiar with the updated Canadian Best-Practice Recommendations for Stroke 
Care?     Y          N 
 
a. If Yes, were the recommendations used when developing your depression 
management strategy?      Y          N 
 
b. If No, were other guidelines/recommendations used to develop your depression 
management strategy?      Y          N   
 
c. If yes to (b), please specify:____________________________________________ 
 
2. Can you briefly describe your existing protocol for management of post-stroke depression? 
 
 
 
 
 
 
 
 
3. Can you please describe any barriers or challenges you experienced when developing your 
protocol? 
 
 
 
 
 
 
 
CANADIAN BEST PRACTICE RECOMMENDATIONS FOR STROKE CARE 
POST-STROKE DEPRESSION 
REHABILITATION MANAGEMENT SURVEY 
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4. Can you please describe any factors that were helpful when developing your protocol? 
 
 
 
 
 
 
 
5. Were resources an issue when developing your protocol and, if so, how were these issues 
addressed? 
 
 
 
 
 
 
 
Part B 
 
1. Are you familiar with the updated Canadian Best-Practice Recommendations for Stroke 
Care?     Y          N 
 
If yes:  
a. Have these recommendations been made available to staff members on your unit?     
Y          N    
    
b. Are you familiar with the specific recommendations for management of post-stroke 
depression?     Y          N 
 
2. Has post-stroke depression been identified as a concern on your unit?     Y          N 
 
3. In your opinion, why has no protocol for management of post-stroke depression been 
developed? 
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4. If a post-stroke depression management strategy were to be developed on your unit, what 
do you feel would be the greatest challenges that would need to be overcome? 
 
 
 
 
 
 
 
5. What factors or features of your unit might be most helpful in developing a practice protocol 
for depression?   
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